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The co-occurrence of mental illness and substance use disorders (termed “dual 
diagnosis”) represents a significant public health issue and is associated with significant 
impairment and negative health consequences, particularly among individuals with 
serious mental illness. Given the negative consequences associated with dual diagnosis, 
researchers have sought to identify treatment components that would improve outcomes 
among individuals with serious mental illness. Therefore, significant efforts have been 
made to increase motivation for change within severe mental illness populations using 
Motivational Interviewing, a client-centered therapy. The primary mechanism underlying 
the effect of Motivational Interviewing on behavior change is hypothesized to be the 
selective reinforcement of change talk by the therapist with the aim of reducing 
ambivalence. Change language has been found to predict substance use treatment 
outcomes; however, it is not clear if change language has similar predictive utility in 
 
 
individuals with serious mental illness. Therefore, the current study sought to validate 
change language as an indicator of motivation among 45 individuals with serious mental 
illness and co-occurring substance use disorders. Overall, we found that change language 
could be reliably coded in this sample. Evidence supported the predictive utility of 
Ability language (i.e., statements regarding self-efficacy) in prospectively predicting long 
term substance use treatment outcomes (i.e., six months after the Motivational Interview 
session)  above and beyond negative symptoms, depressive symptoms, and substance use 
severity. These findings suggest that the investigation of client language during MI 
represents a promising avenue for understanding motivational processes underlying 
substance use treatment outcomes among individuals with serious mental illness. 
Specifically, elicitation of client statements regarding self-efficacy to reduce or stop 
substance use is particularly important in predicting favorable outcomes in this 
population. Future studies should evaluate the utility of incorporating treatment 
components aimed at cultivating self-efficacy for substance use behavior change among 
















PSYCHOLINGUISTIC INDICATORS OF MOTIVATION FOR SUBSTANCE USE 
BEHAVIOR CHANGE AMONG INDIVIDUALS WITH SERIOUS MENTAL 











Dissertation submitted to the Faculty of the Graduate School of the 
University of Maryland, College Park in partial fulfillment 
of the requirements for the degree of 















Professor Jack J. Blanchard, Ph.D., Chair 
Professor Melanie Bennett, Ph.D. 
Professor Shannon Couture, Ph.D. 
Professor Karen O’Brien, Ph.D. 

























© Copyright by 







To my mother, sister, father, and Wanda, who have witnessed this long journey. In 1998, 
I would have never envisioned being where I am now; and without you I could not have 
made it from darkness into the light. Also to my mentors, cheerleaders, and friends, 
Sherry and Chi-Ah who talked me through the insanity of this thing called graduate 
school and gave me the reminders, guidance, and friendship that I needed to get through. 
Finally, I need to give thanks to Kobe and my graduate school compadres, Amy, Bryann, 




Table of Contents 
 
 
Table of Contents ............................................................................................................... iii 
List of Tables ..................................................................................................................... iv 
Chapter 1: Introduction ....................................................................................................... 1 
Dual Diagnosis ................................................................................................................ 1 
Dual Diagnosis and Substance Use Treatment ............................................................... 3 
Motivational Interviewing .............................................................................................. 5 
The Relevance of Motivation in Serious Mental Illness ............................................... 12 
Motivational Interviewing for Substance Use in Dually Diagnosed Individuals ......... 14 
Change Language as an Indicator of Motivation to Change ......................................... 19 
Rationale and Aims ....................................................................................................... 29 
Chapter 2: Method ............................................................................................................ 39 
Participants .................................................................................................................... 39 
Procedure ...................................................................................................................... 40 
Measures ....................................................................................................................... 41 
Change Language and Therapist Language Coding ..................................................... 46 
Chapter 3: Results ............................................................................................................. 51 
Chapter 4: Discussion ....................................................................................................... 76 
Appendix A: Treatments for Dual Diagnosis ................................................................. 103 
Appendix B: Therapist-prompted and Unprompted language ........................................ 106 






















List of Tables 
Table 1 Descriptives for demographic data 51 
Table 2 Clinical characteristics of the sample 52 
Table 3 Base rates of client change language 53 
Table 4 Summary data and ICCs for mean client language frequency ratings 54 
Table 5 Summary data and ICCs for mean client language strength ratings 54 
Table 6 Intercorrelations of language variables 56 
Table 7 Correlations of URICA and C-SOC with change language frequency 57 
Table 8 Correlations of DASE, DBD, and POC-D with change language 
frequency 58 
Table 9 Correlations of PANSS negative symptoms and change language 
frequencies and partial correlations (controlling for depressive symptoms) 59 
Table 10 Zero-order and partial correlations (controlling for depressive 
symptoms) of PANSS negative symptoms and alogia with client verbosity 60 
Table 11 Summary data and ICC for Motivational Interviewing-consistent 
therapist behaviors and correlations of MICO behaviors with change language 
strength and frequency 62 
Table 12 Hierarchical regression analysis of change language frequency 
predicting long-term treatment attendance 64 
Table 13 Hierarchical regression analysis of change language frequency 
predicting long-term substance use (as indexed by the number of clean 
urinalyses 65 
Table 14 Correlations between self-report measures of motivation to change 
and substance use treatment outcomes 67 
Table 15 Correlations between MICO therapist behaviors and substance use 
treatment outcomes 68 
Table 16 Correlations of readiness to change measures with change language 
strength 71 
Table 17 Correlations and partial correlations (controlling for depressive 





Chapter 1: Introduction 
Dual Diagnosis 
Approximately five million adults in the United States have a serious mental 
illness and a co-occurring substance use disorder (SAMHSA, 2006). This comorbidity, 
otherwise known as dual diagnosis, occurs at greater than chance levels both in the 
United States and around the world (Grant & Harford, 1994; Kessler, 1997; Kessler, 
Aguilar-Gaxiola, Andrade, Bijl, Borg, Caraveo-Anduaga et al., 2001; Regier, Farmer, 
Rae, Locke, Keith, Judd et al., 1990). For example, the United States National 
Comorbidity Survey (NCS) found that in a national sample of 10,000 randomly sampled 
individuals in the general population, approximately 51% of individuals with any lifetime 
substance use disorder also met DSM-III-R criteria for at least one other psychiatric 
disorder.  
Comorbid psychiatric disorders with substance use disorders is associated with a 
host of negative health and societal outcomes. Often, co-occurrence is associated with 
increased severity of substance use, the co-occurring disorder, or both. For example, dual 
diagnosis has been found to be associated with increased cocaine dependence severity 
(Ford, Gelernter, DeVoe, Zhang, Weiss, Brady, et al., 2009) and increased severity of 
psychiatric disorders in general (Cacciola, Alterman, McKay, & Rutherford, 2001; 
Compton, Thomas, Conway, & Colliver, 2005b; Kidorf, Disney, King, Neufeld, 
Beilenson, & Brooner, 2004, Mills, Teesson, Ross, & Darke, 2007; Skinstad & Swain, 
2001; Watkins, Hunter, Wenzel, Tu, Paddock, Griffin et al., 2004). Thus, individuals 
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with serious mental illness
1
 such as major depressive disorder, bipolar disorder, and 
schizophrenia face significant social and occupational impairment. 
Individuals with schizophrenia face a host of unique problems associated with 
drug use which adversely impact the course of the illness (Kessler et al., 1994) as well as 
response to treatment. Specifically, among individuals with schizophrenia, substance use 
disorders have been found to be associated with increased medication non-compliance 
(Fenton, Blyler, & Heinssen, 1997; Olfson, Mechanic, Hansell, Boyer, Walkup, & 
Weiden, 2000), symptom exacerbation (Corcoran, Kimhy, Stanford, Khan, Walsh, 
Thompson, et al., 2008; Drake, Osher, & Wallach, 1989; Pristach & Smith, 1990;), 
hospitalizations (Leon, Lyons, Christopher, & Miller 1998; Seibyl, Satel, Anthony, 
Southwick, Krystal, & Charney, 1993), departure from supported independent living 
programs (Lee, Wong, & Rothbard, 2009), risk of homelessness, unemployment 
(Kooyman, Dean, Harvey, & Walsh, 2007), Human-Immunodeficiency Virus risk 
(Himelhoch, McCarthy, Ganoczy, Medoff, Dixon, & Blow, 2007), violent crimes (Fazel, 
Langstrom, Hjern, Grann, & Lichtenstein, 2009), and suicide risk (Limosin, Loze, 
Philippe, Casadebaig, & Rouillon, 2007). Furthermore, families of dually diagnosed 
patients, who are often caregivers, face significant burden, distress, and familial conflict 
(Cleary, Hunt, Matheson, & Walter, 2008).  
In clinical settings, co-occurring major depressive disorder and substance use 
disorder represents the most common comorbidity. Approximately one-third of 
                                                 
1
  The National Institute of Mental Health defines serious mental illness as those psychiatric 
disorders that meet the following criteria: (1) are non-organic psychosis or personality disorder, (2) have 
long histories of previous hospitalization or outpatient treatment, and (3) are associated with dangerous or 
disturbing social behavior and significant impairment in social and occupational functioning and mild 
impairment in basic needs (Ruggeri, Leese, Thornicroft, Bisoffi, & Tansella, 2000). Others define serious 
mental illness are less conservative, not requiring the psychosis component, yet require long treatment 
history and severe social and occupational impairment.  
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individuals with major depressive disorder have a substance use disorder (Davis, Uezato, 
Newell, & Frazier, 2008). This comorbidity is associated with increased risk for suicide 
and increased social impairment. One study found that co-occurring major depressive 
disorder and alcohol dependence was associated with a 20-fold increase in risk for 
suicide during the year prior to assessment compared to individuals with neither disorder 
(Currie, Patten, Williams, Wang, Beck, El-Guebaly, et al., 2005). In another study 
(Aharonovich, Liu, Nunes, & Hasin, 2002), co-occurring major depressive disorder and 
substance use disorder was associated with the number and severity of suicide attempts. 
Furthermore, Currie et al. (2005) found that major depressive disorder and co-occurring 
substance use disorders were associated with a 3.1-6.4 increase in use of mental health 
services. Those with these co-occurring disorders also benefit less from 12-Step groups 
than those without co-occurring disorders (Kelly, McKellar, & Moos, 2003). 
In patients with bipolar disorder and a co-occurring alcohol use disorder, alcohol 
use is associated with an increased risk of a depressive episode (Jaffee, Griffin, Gallop, 
Meade, Graff, Bender, et al., 2009). Moreover, bipolar disorder with co-occurring SUDs 
has been linked to increased social dysfunction and increased manic symptoms compared 
to those with bipolar and no substance use disorder (Mazza, Mandelli, Di Nicola, Harnic, 
Catalano, Tedeschi, et al., 2009). 
Dual Diagnosis and Substance Use Treatment 
Given the negative consequences associated with dual diagnosis, researchers have 
sought to identify treatment components that would improve outcomes among individuals 
with serious mental illness. Research advocating integrated treatment approaches has 
identified various areas that should be targeted in order to maximize treatment 
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effectiveness. While a full discussion of the various identified treatment targets and 
strategies is beyond the scope of the current study (although see Appendix A for a more 
detailed discussion of integrated dual diagnosis treatment) one consistent treatment 
barrier has been identified. Specifically, dually diagnosed clients seeking treatment for 
psychiatric problems are often not ready to seek treatment for their substance use, or do 
not recognize their substance use as needing to be addressed. This problem is enhanced in 
those with psychosis, who are often difficult to engage in treatment and who are at 
increased risk for dropout (Barrowclough, Haddock, Lowens, Allott, Earnshaw, 
Fitzsimmons, et al., 2007).  
A key factor underlying poor treatment outcomes among individuals with serious 
mental illness has been hypothesized to be low motivation (Barrowclough, Haddock, 
Fitzsimmons, & Johnson, 2006). Specifically, negative symptoms are the core features 
which reflect motivational deficits in schizophrenia. They include avolition, anhedonia, 
amotivation, alogia, apathy, and flat affect (McGlashan & Fenton, 1992). Such 
symptomatology can potentially restrict the behavioral repertoire of patients seeking 
treatment and thus undermine motivation during the complex series of actions required to 
seek treatment and maintain abstinence from substances. Therefore, significant efforts 
have been made to increase motivation for change within serious mental illness 
populations. One approach has been through the use of motivational enhancement 
techniques. To this end, Motivational Interviewing has emerged as a promising method of 
improving treatment outcomes among individuals with serious mental illness.  
The current review will focus on the foundations of the Motivational Interviewing 
approach (Miller, 1983; Miller & Rollnick, 1991) followed by a brief discussion of 
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Motivational Interviewing treatment components. Then, I will summarize the findings 
concerning the effectiveness of Motivational Interviewing in dually diagnosed 
populations. Finally, I will discuss the mechanisms by which this treatment works, 
namely, the role of motivational change language in accounting for substance use 
treatment outcomes. 
Motivational Interviewing 
Motivational Interviewing is a client-centered, directive therapeutic style 
(directive in that the therapist directs the course of therapy by intervening to ask 
questions and offer interpretations) aimed at enhancing readiness for behavior change 
(Miller, 1983; Miller & Rollnick, 1991). Motivational Enhancement Therapy is a variant 
of Motivational Interviewing designed as a treatment for use in Project Match (a large-
scale alcohol treatment study, see Project Match Research Group, 1993). In Motivational 
Enhancement Therapy, a personalized feedback component is integrated into the 
sessions. Although Motivational Interviewing and Motivational Enhancement Therapy 
were initially used for addictive behaviors, they have spread rapidly as an effective non-
prescriptive approach to enhancing motivation for behavior change with respect to a 
variety of health behaviors (Hettema, Steele, & Miller, 2005). 
Motivational Interviewing was initially developed as a method to assist clients in 
resolving their ambivalence regarding behavior change and eventually reach a point 
where they may commit to change (Miller, 1983). Although Motivational Interviewing 
was not founded on theory (Miller & Rollnick, 2004), it borrows from Rogerian client-
centered therapy (Rogers, 1959). The principles of Motivational Interviewing (explained 
in subsequent sections), were outlined prior to any empirical support or theory. A 
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substantial theoretical contribution has been within the framework of Prochaska and 
DiClemente’s (1982) Transtheoretical Model of Change, which describes the progression 
from ambivalence regarding behavior change to a commitment to change, and then 
finally into taking active steps to change.  
Rogerian patient-focused treatment.  Carl Rogers, a humanistic psychologist, 
embraced the importance of an empathetic and warm therapeutic style (Rogers, 1959). 
Empathy is the ability of the therapist to put himself/herself in the situation of the client 
and to understand the experience of the patient without imposing judgment. Warmth is 
defined as unconditional positive regard for the client, which is conveyed through 
positive affect and body language. Rogers also emphasized the importance of the 
therapist to be oneself and feel comfortable in the therapeutic relationship (genuineness), 
and to react to the client in the moment (immediacy). 
 Client-centered therapy seeks to “meet the client where they are at.” To this end, 
the therapist seeks to understand what changes, if any, the patient is ready to make, rather 
than the therapist imposing his/her views of what types of changes the patient should be 
making. In all, the client-centered approach relies on the client’s perception of the 
problem and the therapist’s role is to collaborate with the client to address problems. The 
acceptance and egalitarianism inherent in the client-centered approach to therapy was 
appealing to Miller; hence, the Rogerian approach to therapy is ever-present in 
Motivational Interviewing. 
 MI assumes all of the aforementioned principles of client-centered therapy; 
however, the point of departure between the two approaches is in the directive nature of 
MI. This is in contrast to client-centered therapy, in which the therapist assumes a non-
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directive role; it is assumed that the client will eventually reach self-actualization and 
move toward change. In MI, the therapist actively moves the client toward positive 
change, and points out inconsistencies in his/her behavior in order to build motivation for 
change. This is achieved through various therapist skills outlined in subsequent sections. 
Nevertheless, advice is not given unless the client agrees to hear it. 
Transtheoretical model of change. Another substantial influence on 
Motivational Interviewing was Prochaska and DiClemente’s (1982) Transtheoretical 
Model of Change, which describes the process through which individuals who are 
recovering from addiction move through various stages of change as they resolve their 
difficulties with substance use. The Transtheoretical Model of Change, developed in 
parallel with motivational approaches to changing health behaviors, was a large influence 
on Miller’s development of the Motivational Interviewing approach. Specifically, 
motivation is seen as the springboard which propels clients through the six stages of 
change, which are Precontemplation, Contemplation, Preparation, Action, and 
Maintenance.  
In the Precontemplation stage, the substance user has no interest in changing 
substance use behavior. If a sense of concern arises, the individual is thought to move to 
the Contemplation stage, wherein the benefits and drawbacks to changing behavior are 
considered. In the Preparation stage (Pantalon, Nich, Franckforter, & Carroll, 2002), the 
individual is thought to commit and begin planning to change. In the Action stage, the 
individual takes specific steps to execute the plan to change. In the final stage, 
Maintenance, the reduction of, or abstinence from, substance use becomes habitual. 
Although theorists hypothesize individuals may move back and forth through the stages, 
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they propose individuals do not skip stages when moving forward (DiClemente, 
Schlundt, & Gemmell, 2004).  
During Motivational Interviewing sessions, and consistent with the 
Transtheoretical Model of Change, clients are seen as agents of change and therapists are 
to “meet the client where they are,” rather than attempting to convince them that they 
need to change. Motivational Interviewing techniques are designed to allow the client to 
explore their ambivalence regarding change at each stage. Although some individuals 
make it to the maintenance stage and remain abstinent from substances, most progress 
through these stages repeatedly throughout their lifetime.  
Principles of Motivational Interviewing 
In recent years, Motivational Interviewing has been used as a standalone 
intervention or as a complement to other substance use treatment approaches.  The 
number of Motivational Interviewing sessions provided depends on the goals of the 
intervention, the treatment setting, and whether it is being integrated with other treatment 
components. Therefore, the number of sessions may be as few as one. Also, session 
lengths can vary from 20 minutes in Brief Motivational Interviewing to 90 minutes in 
some contexts.  
The “spirit of MI” is conveyed through principles that are adhered to by the 
therapist using what are called Motivational Interviewing microskills. Also, there are 
specified strategies that therapists must use in order to increase intrinsic motivation to 




The four principles of Motivational Interviewing are (1) express empathy, (2) 
develop discrepancy, (3) roll with resistance, and (4) support self-efficacy (Miller, 
Zweben, DiClemente, & Rychtarik, 1992). These principles work in concert with the 
factors that encompass the “spirit of MI,” which are collaboration, evocation or eliciting 
(rather than imparting wisdom), and autonomy (in contrast to making, allowing, or 
permitting the client, etc.).  
Empathy.  With respect to empathy, it is believed that when clients feel that the 
therapist understands them, they are more likely to share their deepest thoughts and 
feelings and less likely to deny problems. In this way, the therapist creates a space that is 
conducive to change. Therefore, empathy is thought to facilitate behavior change. 
Empathy is achieved through the use of the therapeutic skill of reflective listening, 
wherein the therapist shows the client that his/her feelings and beliefs are valid without 
criticism, judgment, or blame (Miller & Rollnick, 2002). This is in sharp contrast to many 
confrontational substance use treatment approaches wherein clients are constantly sent 
messages that they are somehow defective and have to change. This confrontational 
approach has actually been found to hinder change processes in some contexts (Finney, 
Wilbourne, & Moos, 2007). Instead, the therapist seeks to understand the client within 
their context (i.e., his/her environment and experiences), and convey to the client that 
their behavior makes sense within his/her context. 
Develop discrepancy. This principle represents the directive portion of 
Motivational Interviewing. Whereas traditional client-centered therapy is non-directive, 
Motivational Interviewing seeks to direct clients toward resolving ambivalence. One way 
is through developing discrepancy between what the client’s current behavior is and what 
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their goals are. It is believed that when individuals see their present circumstances as 
being inconsistent with their goals, positive behavior change is more likely to occur. 
Therefore, in Motivational Interviewing discrepancies are magnified until the client sees 
the target behavior as something that they should strive to change. 
Roll with resistance. The concept of rolling with resistance is consistent with 
non-confrontational approaches. Indeed, according to this framework, it would be 
counterproductive for the therapist to encourage change while the client disputes it 
(Miller, 2002). Instead, the therapist involves the client in the resolution of ambivalence 
regarding change. This is in line with encouraging autonomy. Moreover, resistance is not 
a signal that there is something wrong with the client; rather, it signifies that the therapist 
should change approaches.  
Self-efficacy. By supporting and encouraging the client’s belief in his or her 
ability to reduce or abstain from substance use and encouraging autonomy, the client’s 
confidence in coping with obstacles to his/her substance use goals increases. In this way, 
change is intrinsically motivated, rather than externally imposed. Again, this is in direct 
contrast to approaches such as 12-Step oriented recovery, wherein the substance user is 
convinced that he/she is powerless and has no control over their use; rather, only through 
belief in a higher power can his/her substance use issues be resolved. 
Microskills and Strategies 
 There are four Motivational Interviewing microskills that therapists use to ensure 
that the principles of Motivational Interviewing are adhered to. These are the use of open-
ended questioning, reflective listening, using affirmations, and summarizing the patient’s 
statements in a balanced fashion. Furthermore, Motivational Interviewing strategies are 
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techniques used by the therapist to build intrinsic motivation to change. These include (1) 
increasing awareness of the client’s problems using open-ended questions, (2) using 
decisional balance matrices (i.e., discussing the pros and cons of using and 
reducing/stopping substance use), (3) providing supportive feedback regarding the 
client’s thoughts and actions, and (4) pointing out discrepancies between the client’s 
goals and current behavior in a non-patronizing manner. 
 In discussing the principles and therapist techniques used in MI, it becomes 
apparent that motivation is indeed a salient factor in progression through the stages of 
change and is a vital mechanism that determines whether one succeeds in performing a 
given behavior (Bandura, 1986), including changing substance use patterns (Miller, 
1985). During each stage of the Transtheoretical Model of Change, motivational factors 
are involved in projecting the client from one stage to the next. Specifically, one’s 
concerns regarding behavior change, perceived needs to change, intentions, and 
commitment to change may all be subsumed under the umbrella of the concept of 
motivation (DiClemente, Schlundt, & Gemmell, 2004). With respect to substance use 
treatment engagement, motivation is involved in participating in treatment activities and 
being compliant in treatment. Motivation also drives the ability to maintain goals 
regarding substance use.  In support of this notion, numerous studies have found that 
motivation for treatment predicts treatment engagement and retention. Furthermore, 
increased motivation has been associated with reduced substance use (Carbonari & 
DiClemente, 2000; DeLeon, Melnick, & Kressel, 1997; DeLeon, Melnick, Thomas, 
Kressel, & Wexler, 2000; Joe, Simpson, & Broome, 1998; Project MATCH Research 
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Group, 1997; Pantalon et al., 2002; Simpson & Joe, 1993; Stotts, Schmitz, Rhoades, & 
Grabowski, 2001). 
The Relevance of Motivation in Serious Mental Illness 
According to the Transtheoretical Model of Change framework, moving through 
the readiness stages requires significant motivation in that it necessitates engagement in a 
variety of behaviors in order to begin and maintain change. In this way, intentional 
behavior change associated with reducing substance use requires significant insight, 
decision-making processes, planning, evaluation of pros and cons, sustained focus on 
goals, and evaluation of one’s self-efficacy. Individuals with serious mental illness 
frequently have cognitive impairments which interfere with these processes (Blume, 
Davis, & Schmaling, 1999). Moreover, some psychiatric disorders, particularly those on 
the schizophrenia spectrum, have core features which reflect deficits in motivation in the 
form of negative symptoms (e.g., avolition, anhedonia, amotivation) (Brown & Pluck, 
2000; Weinberger, 1987). Furthermore, psychotic disorders are also associated with 
positive symptoms (e.g., hallucinations) and disorganization which could impact the 
ability to evaluate various options to achieve behavior change. Thus, motivational issues 
are a particularly salient complication in the treatment of dually diagnosed individuals. 
Such difficulties are evident in their lack of treatment engagement when compared to 
non-dually diagnosed substance users (Bender, Springer, & Kim, 2006). Those with 
schizophrenia, a particularly impaired group among those with dual diagnosis, exhibit 




The significance of motivation in treating substance use among individuals with 
serious mental illness has been addressed by numerous researchers (Bellack, 2007; 
Carey, Carey, Maisto, & Purnine, 2002; Martino, 2007). In response to the call to address 
this issue, motivational interventions have been adapted for individuals with serious 
mental illness for use in integrated treatments (e.g., Bennett, Bellack, & Gearon, 2008; 
Bennett, Bellack, & Gearon, 2001; Carey, Leontieva, Dimmock, Batki, & Maisto, 2007).  
Drake, Mueser, Brunette, and McHugo (2004) found that among the seven interventions 
commonly used for dual diagnosis, those that incorporated treatment components which 
target stages of motivation appear to be most effective. Furthermore, motivation has been 
found to predict substance use treatment engagement and outcomes in dual diagnosis 
samples (Miller & Tonigan, 1996; Ries & Ellingson, 1990; Zhang, et al., 2004). 
Nevertheless, in some studies, motivation was not found to predict engagement or 
treatment retention (Pantalon & Swanson, 2003; Ziedonis & Trudeau, 1997). Although 
these conflicting findings could be attributable to methodological issues, it could also 
indicate that internal motivation may not be as strongly tied to substance use outcomes 
within this population as other factors such as external motivators.  Moreover, given 
negative symptoms and their impact on motivation in individuals with serious mental 
illness, it is not clear precisely how symptomatology may influence research findings. 
Also, it would be fruitful to explore behavioral indicators of lack of motivation (such as 
lack of expressivity during therapy sessions) in individuals with serious mental illness. 
Therefore, further investigation into the precise nature of motivational processes and their 
relationship with serious mental illness symptomatology is necessary. A review of 
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Motivational Interviewing, an intervention which has been used to target lack of 
motivation, is provided in the next section. 
Motivational Interviewing for Substance Use in Dually Diagnosed Individuals 
MI has evidenced effectiveness in improving treatment engagement and reducing 
substance use in non-serious mental illness populations (Hettema et al., 2005; Vasilaki, 
Hosier, & Cox, 2006). Although there are fewer studies examining the effectiveness of 
Motivational Interviewing in dually-diagnosed populations, there is promising evidence 
that Motivational Interviewing is effective as a standalone treatment, as well as an 
adjunct to other approaches, in improving treatment engagement and outcome. Most 
integrative treatments for dually diagnosed individuals incorporate a motivational 
enhancement element in combination with behavioral approaches (e.g., Bellack, et al., 
2006; Carey, 1996; Martino, Carroll, Kostas, Perkins, & Rounsaville, 2002). In these 
studies, it is not possible to determine the relative contributions of each treatment 
component (e.g., Barrowclough, Haddock, Terrier, Lewis, Moring, O’Brien, et al., 2001); 
however, a few controlled studies have investigated the utility of Motivational 
Interviewing in improving treatment engagement and outcomes. These studies are 
discussed below. 
 Swanson, Pantalon, and Cohen (1999) conducted a randomized study examining 
the effect of Motivational Interviewing on outpatient substance use treatment adherence. 
Patients were assigned to a treatment as usual or to treatment as usual with MI. Patients 
were given a brief motivational assessment early in hospitalization and then underwent an 
hour-long Motivational Interviewing session shortly before being discharged. Results 
indicated that a significantly greater proportion of individuals in the treatment as usual 
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plus Motivational Interviewing group attended the first outpatient appointment. This 
effect was significantly greater among individuals who were dually diagnosed.  
 A pilot study (Martino, Carroll, O’Malley, & Rounsaville, 2000) compared the 
efficacy of Motivational Interviewing to standard pretreatment interviewing in preparing 
patients for partial hospitalization. The sample consisted of drug or alcohol dependent 
individuals with mood or psychotic disorders. Patients were randomly assigned to a 45-
60 minute Motivational Interviewing session or to a standard pre-admission interview. 
Those in the Motivational Interviewing group exhibited less tardiness to groups, fewer 
early departures, and attended more partial hospital program days than those in the 
standard interviewing group. Furthermore, individuals with psychosis had better 
outcomes overall on these measures than those with mood disorders. Although there was 
not enough power in the study to examine diagnostic differences by treatment group, 
these findings hint that enhancing motivation in a psychotic population may produce 
better outcomes. The above studies suggest that treatment attendance can be improved 
with MI, but do not address substance use reduction.  
Graeber, Moyers, Griffith, Guajardo, and Tonigan (2003), assessed patients with 
schizophrenia and alcohol use disorders and randomly assigned individuals to receive 
three one-hour sessions of Motivational Interviewing or an Educational Treatment 
intervention. Follow-ups at 4, 8, and 24 weeks indicated that patients in the Motivational 
Interviewing group had significantly fewer drinking days and increased abstinence rates 
at the 8- and 24-week follow-up compared to those in the ET group. Notably, despite a 
small sample size, (n = 30) the between-group effect size at week 24 was 1.29, indicating 
a large effect (Cohen, 1988). 
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 A study investigating the effectiveness of Motivational Interviewing in reducing 
alcohol and drug use among psychiatric hospital inpatients (Baker, Lewin, Reichler, 
Clancy, Carr, Garrett, et al., 2002) randomly assigned patients to either a single session of 
Motivational Interviewing or a self-help condition.  Follow-up assessments were 
conducted at 3, 6, and 12 months. Approximately 38% of the sample met criteria for 
schizophrenia, 28% for mood disorders, 13% for other disorders, and 21% did not meet 
criteria for any disorder.  Although the effect of Motivational Interviewing on reductions 
in alcohol, cannabis, or amphetamines use were not significant, there was a modest effect 
of Motivational Interviewing in reducing polysubstance use at the 3-month follow-up. No 
diagnostic relationships to outcome were explored.  Consistent with these null findings, 
Hulse and Tait (2003) compared the 5-year outcomes of individuals in an inpatient 
psychiatric hospital who were assigned to receive either one Motivational Interviewing 
session or given an information package  that was designed to encourage the reduction of 
alcohol use. Results revealed no differences between the two conditions in terms of the 
occurrence of alcohol-related incidents. 
 Martino, Carroll, Nich, and Rounsaville (2006) conducted a pilot randomized 
controlled trial comparing Motivational Interviewing to standard psychiatric interviews 
among patients with psychotic and drug use disorders. Results at 4-, 8-, and 12-week 
follow-ups indicated no benefit of either condition; however, among cocaine users, those 
who received Motivational Interviewing demonstrated significantly greater reduction in 
use than those who received the standard psychiatric interview. Among marijuana users, 
the reverse was found. Those who received the standard psychiatric interview reported 
significantly greater reductions in use than those in the Motivational Interviewing group. 
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These results did not differ after considering baseline motivation for change scores. 
However, the group as a whole had high levels of motivation to change based on their 
stage of change profile. This may have affected the effectiveness of Motivational 
Interviewing which has been found to work better in individuals with low motivation 
(Miller & Rollnick, 2002).  
 The aforementioned studies provide equivocal evidence for the effectiveness of 
Motivational Interviewing among populations of diagnostically heterogeneous samples. 
Moreover, few have examined the benefit of Motivational Interviewing for individuals 
with serious mental illness or, more specifically, the relative benefit for individuals with 
schizophrenia or schizoaffective disorder. Also, the clinical characteristics of the sample 
are often not described and if they are, the sample often contains individuals with various 
disorders, thus not allowing for adequate power to explore the impact of specific 
symptomatology on Motivational Interviewing outcomes and motivational processes. It is 
possible that by examining potential moderators, such as symptomatology or indicators of 
motivation, the results could have been better accounted for. 
 Another potential explanation for these equivocal findings regarding the 
effectiveness of Motivational Interviewing may be found by investigating how the 
process of change works among individuals with serious mental illness. Given the 
cognitively complex process of moving from initiating treatment, engaging in behavioral 
activities necessary to progress through treatment, and to maintaining change, the process 
of intentional change in this cognitively impaired population remains unclear. Also, given 
the features of serious mental illness which affect motivation (e.g., symptoms of 
avolition, anergia), it could be that external reinforcers are what drive the behavior 
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change process more than in those without co-occurring disorders (Bellack & 
DiClemente, 1999). To this end, it would be fruitful to examine the relationship of 
symptomatology to change processes and whether such change processes work in the 
same fashion among individuals with serious mental illness as they do among populations 
without serious mental illness. 
Significant research has been conducted on motivational processes involved in 
reducing substance use using various indicators of readiness to change among individuals 
without serious mental illness. Among dually-diagnosed individuals, numerous measures 
of motivation change have been validated (see DiClemente, Nidecker, & Bellack, 2008) 
and support has been lent to the idea that dually diagnosed individuals do indeed utilize 
intentional behavior change processes (DiClemente, Nidecker, & Bellack, 2008). The 
examination of motivational processes has largely been achieved through the use of self-
report measures. Specifically, measures that tap readiness to change (e.g., University of 
Rhode Island change Assessment – Maryland, DiClemente & Hughes, 1990; Cartoon 
Stages of Change Measure, Clark, Wells, Peterson, Jackson, & Stanton, 1996), the 
confidence the client has in their ability to resist drugs and alcohol (e.g., Drug and 
Alcohol Abstinence Self-Efficacy Scales, DiClemente, Carbonari, Montgomery, & 
Hughes, 1994), the client’s perceived costs and benefits of using drugs and drinking 
alcohol (e.g., Decisional Balance Scales, Velicer, DiClemente, Prochaska & 
Brandenburg, 1985), and the behavioral processes that clients use in order to resist the 
use of drugs and alcohol (e.g., Processes of Change Scale, DiClemente, Carbonari, Addy 
& Velasquez, 1996), have all been associated with changes in smoking, drinking, and 
drug use (Carbonari & DiClemente, 2000; Naar-King, Wright, Parsons, Frey, Templin, & 
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Ondersma, 2006; Schumann, Meyer, Rumpf, Hannover, Hapke, & John, 2005) and have 
been validated in a sample with serious mental illness and substance use disorders 
(Nidecker, et al., 2006).  
An alternative approach to examining self-report measures of motivation is to 
look at behavioral indicators of motivation and to examine how motivation is manifested 
linguistically during the therapeutic process. Specifically, motivational language offers 
insights into change processes during substance use treatment and allows for hypotheses 
regarding motivation. Motivational language has been the focus of recent studies 
examining substance use behavior change processes, but has not been examined in 
individuals with serious mental illness.  An overview of the significance of self-
motivational statements, or change talk, in therapeutic processes is provided below, as 
well as a review of studies investigating the role of change language in predicting the 
modification of substance use behavior. 
Change Language as an Indicator of Motivation to Change 
A prominent idea that has been discussed since Freud’s time is that language 
during psychotherapy is associated with behavior during therapy (Russell, 1987). Out of 
the numerous psychotherapeutic constructs and processes that have been codified across 
the many therapeutic orientations (e.g., the emergence of specific themes, repetition of 
particular utterances thought to be indicative of subconscious processes, changes in 
verbal intonation), measurement of the changing of target behaviors emerged as an 
indicator that is key in understanding the relationship between therapeutic processes and 
outcome (Greenberg & Pinsof, 1986). Indeed, intention to change is the basis for the 
Transtheoretical Model of change (Prochaska & DiClemente, 1982), the dominating stage 
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model of substance use behaviors.  Therefore, the measurement of indicators of intention 
to change behavior is also useful in examining therapeutic processes. 
Amrhein (2004) proposed a Motivational Interviewing process model based on 
natural language indicators of clients’ intentions to change. As such, the codification of 
natural language is based on speech act theory (Schiffrin, 1994; Searle, 1969), which 
underscores the intentional function of certain utterances during conversation. This has 
direct applications to the long-held approach by therapists of various orientations to 
promote the client’s commitment to change troubling behaviors during “talk therapy”. 
Also, from the perspective of cognitive dissonance theory (Festinger, 1957), committing 
oneself to a certain action in public creates an obligation to perform the act, else face a 
sense of cognitive dissonance. To tap into this process of “talking oneself into change,” 
(Miller & Rollnick, 2004), Amrhein indicated (1992) that instead of relying on checklists 
and self-report measures of commitment to change, a seemingly more valid method of 
assessment is through the psycholinguistic analysis of client language during 
Motivational Interviewing sessions. To this end, the client’s stated desire and self-
efficacy regarding the reduction of substance use serve as indicators of commitment to 
change, or change talk. Some have used the phrase “ready, willing, and able” to 
characterize each of the components underlying commitment to change: desire, ability, 
need, reasons and readiness (Amrhein, 1992; Amrhein, Miller, Yahne, Plamer, & 
Fulcher, 2003; Miller & Rollnick, 1991).  
The primary mechanism underlying the effect of Motivational Interviewing on 
behavior change is hypothesized to be the selective reinforcement of change talk by the 
therapist with the aim of reducing ambivalence (Miller& Rollnick, 2002). Furthermore, in 
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order to increase the likelihood of change, rather than resistance, non-confrontational 
language by the therapist is thought to create a supportive therapeutic environment. Both 
of these elements are captured by coding client and therapist behaviors (language) using 
the Motivational Interviewing Skills Code (MISC; Miller, Moyers, Ernst, & Amrhein, 
2003) to analyze the frequency of change talk. For the therapist, adherence to the spirit of 
Motivational Interviewing is captured through coding on various dimensions based on the 
principles and strategies of Motivational Interviewing (e.g., using non-confrontational 
responses, not giving unsolicited advice). For the patient, language that indicates 
commitment to change is coded as well as statements that indicate an inclination not to 
change. Additionally, language that indicates that the patient is taking steps to change is 
coded. For all of the aforementioned codes, the valence (i.e., for or against behavior 
change) and strength of the language is also coded. 
Another psycholinguistic technique is to perform a sequential analysis of 
behavior, using the Sequential Code for Process Changes behavioral coding system, 
which is derived from the MISC (Miller et al., 2003). In sequential analysis, the 
occurrence of change talk is coded as a function of therapist behavior in order to 
elucidate the contingency between therapist and client behavior. Numerous studies have 
found that MI-consistent therapist behaviors are more likely to be followed by client 
change language (Gaume, Gmel, Faozi, & Daeppen, 2008; Gaume, Bertholet, Faouzi, 
Gmel, & Daeppen, 2010; Glynn & Moyers, 2010; Moyers, Martin, Houck, Christopher, 
& Tonigan, 2009; Vader, Walters, Prabhu, Houck, & Field, 2010), thereby highlighting 
the impact of therapist behaviors on client language. 
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A logical question that arises when considering the potential impact of change 
language on behavior change is whether it is the mere act of producing the language that 
produces change or whether change language is an indicator of some deeper process that 
affects both change language and behavior change. Also, given the significant impact of 
therapist empathy in general on client outcomes (Miller, Taylor, & West, 1980), and 
more specifically, on long-term drinking outcomes (Miller & Baca, 1983), the specificity 
of the effect of Motivational Interviewing on substance use outcomes is easily called into 
question. One study (Aharonovich, Amrhein, Bisaga, Nunes, & Hasin, 2008) found that 
increased commitment language during cognitive behavioral treatment for substance use 
predicted reduced use among cocaine users. This suggests an effect of therapist behavior 
on client behavior that is not specific to MI. However, Miller proposes that Motivational 
Interviewing works through the combination of therapist empathy and factors that are 
specific to MI, such as the resolution of ambivalence through the selective reinforcement 
of change language. Consistent with this proposal, in a study by Sellman et al. (2001), the 
resolution of ambivalence regarding drinking was found to be attributable to the 
differential reinforcement of client change language. 
Further evidence of the effect of MI-specific strategies on therapy processes 
comes from separate studies which support the hypothesis that Motivational Interviewing 
influences client behavior during therapy (Moyers & Martin, 2006; Moyers, Miller, & 
Hendrickson, 2005),  increases change language (Gaume, Gmel, Faozi, & Daeppen, 
2008; Glynn & Moyers, 2010), decreases resistance (Miller, Benefield & Tonigan, 1993), 
and that verbal commitment to change predicts drug use outcomes (Amrhein, Miller, 
Yahne, Palmer, & Flucher, 2003). Nevertheless, the notion that the elicitation of change 
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language during Motivational Interviewing causes behavioral change cannot be 
concluded; however, what is known is that Motivational Interviewing elicits change 
language, which in turn precedes and predicts behavior change. Three separate studies  
examining the effect of Motivational Interviewing skills on change language used 
sequential analysis to provide support this proposed causal chain for Motivational 
Interviewing (Gaume, Bertholet, Faouzi, Gmel, & Daeppen, 2010; Moyers, Martin, 
Houck, Christopher, & Tonigan, 2009; Vader, Walters, Prabhu, Houck, & Field, 2010).  
Also, work by Amrhein (2003), Baer, Beadnell, Garrett, Hartzler, Wells, & Peterson 
(2008), and Vader et al. (2010) have honed in on specific patterns of change language 
during Motivational Interviewing sessions that are predictive of outcomes. These and 
other studies examining therapist behaviors, client change language, and substance use 
outcomes are reviewed below.  
Miller et al. (1993) randomly assigned problem drinkers to either Motivational 
Interviewing or to a confrontational counseling condition. Those in the Motivational 
Interviewing group exhibited significantly more change language and significantly less 
resistance compared to those assigned to the confrontational group. More direct evidence 
for the impact of Motivational Interviewing on eliciting change talk in clients comes from 
within-subject designs, which use probability analyses to examine therapist-client 
interactions. Two sequential analysis pilot studies designed to examine the effect of 
therapist behavior on client language and subsequent substance use behavior change 
during Motivational Enhancement Therapy (Moyers, Martin, Christopher, Houck, 
Tonigan, 2007) found that Motivational Interviewing-consistent behavior was more likely 
to be followed by change language. A later study by the same research group (Moyers et 
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al., 2009) found support for a meditational role of client language wherein the 
relationship between MI-consistent therapist behavior and positive drinking outcomes 
was mediated by change language. Furthermore, evidence suggested that selective 
reinforcement of change language by therapists is a key mechanism underlying the 
effectiveness of Motivational Interviewing. 
Additional evidence of the ability of Motivational Interviewing therapist skills to 
elicit change language in patients comes from two studies by Gaume, et al. (2008) and 
Gaume, et al. (2010). In Gaume, et al. (2008), a sequential analysis of therapist and 
patient language during brief Motivational Interviewing sessions targeting alcohol use (in 
an at-risk sample) was performed using the psycholinguistic codes provided in the 
Motivational Interviewing Skill Code, version 2.0 manual. The study found that 
Motivational Interviewing-consistent therapist behaviors were significantly more likely to 
be followed by client change language than Motivational Interviewing-inconsistent 
behaviors. These findings were replicated in a separate study (Gaume, et al., 2010) using 
a sample of young adults during Brief Motivational Interviewing in a nonclinical setting. 
A study examining the impact of therapist language and personalized feedback on 
client language and subsequent drinking outcomes among college students (Vader, et al., 
2010) provides additional evidence of the link between therapist skills and change talk. 
Participants were assigned to either an Motivational Interviewing session only (MIO) or 
to an Motivational Interviewing session with personalized feedback (MIF). In the MIF 
condition, greater Motivational Interviewing-consistent therapist skills were associated 
with more change language (but not counter-change language). In the MIO condition, 
greater MICO skills were associated with greater change language and counter-change 
25 
 
language. In addition to suggesting the importance of feedback sessions in “tipping the 
balance” toward change language rather than toward counter-change language, these 
findings provide further support for the link between therapist MICO skills and client 
change language. 
Finally, using an ABAB experimental design, Glynn et al. (2010) manipulated the 
therapeutic context in order to examine the effect of treatment modality on the elicitation 
of client change language. Specifically, the prevalence of change language was compared 
in a condition resembling Motivational Interviewing and in a functional analysis 
condition. In the Motivational Interviewing condition, the therapist’s primary focus was 
the selective reinforcement of change language. As hypothesized, greater percentage of 
change talk during the session was associated with the Motivational Interviewing 
condition in comparison to the functional analysis condition, thus providing further 
evidence for the potential causal mechanism of differential reinforcement of change 
language by the therapist during MI.  
The aforementioned studies provide support for the idea that Motivational 
Interviewing-specific therapist skills indeed elicit change language from the client. 
Additional studies, discussed below, provide evidence that change talk predicts substance 
use outcomes.  
Using data from a large clinical trial (Project MATCH Research Group, 1997) 
Moyers, et al. (2007) found that change language accounted for a significant amount of 
variance in drinking outcomes. In another study, Vader, et al (2010) examined the effect 
of client language during Motivational Interviewing on drinking short- and long-term 
outcome (3- and 6-month follow-up) in a sample of students at-risk for alcohol abuse. 
26 
 
Among those receiving Motivational Interviewing with personalized feedback, greater 
frequency of counter-change language predicted poorer alcohol use outcomes, while 
greater frequency of change language predicted positive drinking outcomes at both short- 
and long-term follow-ups. 
In order to examine the role of specific types of change language, Amrhein, et al. 
(2003) investigated commitment language during Motivational Interviewing sessions 
among a sample of substance abusing individuals undergoing Motivational Interviewing. 
The sessions were coded for the frequency and strength of motivationally-relevant 
utterances across entire Motivational Interviewing sessions. While other studies rely on a 
dichotomous conceptualization of change language (i.e., statements for or against 
change), this study codified statements which indicated desire, ability, need, and 
commitment to change. Each language category was counted and assigned a strength 
value. Based on the percentage of days abstinent at 3, 6, 9, and 12 month follow-ups, four 
group clusters (i.e., maintainers, changers, strugglers, and discrepants) emerged with 
varying patterns of commitment language frequency and strength during the Motivational 
Interviewing session. Furthermore, the four groups differed with respect to the mean 
commitment strength across the session, but did not differ with respect to frequency or 
strength of statements indicating desire, ability need, or reasons to change.  
Finally, with respect to substance use outcomes, Amrhein et al. (2003) found that 
commitment language strength exhibited toward the end of the session (when discussing 
a plan for change) was a powerful predictor above and beyond baseline substance use, 
while the other language categories did not significantly predict outcome. Nevertheless, 
consistent with prior research suggesting that desire, ability, need, and reasons to change 
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are underlying dimensions of commitment (Amrhein, 1992), this study did indeed find 
that these language categories accounted for significant unique variance in commitment 
strength. This study not only highlighted the predictive utility of the strength of 
commitment language in substance use treatment outcomes, but it also explained the null 
findings by Miller, Benefield, and Tonigan (1993), in which commitment frequency 
during the first twenty minutes of session was used as a predictor of outcome. Amrhein et 
al. (2003) demonstrated the predictive power of examining language strength across the 
entire session. 
In order to assess the role of cognitive abilities and change language in substance 
use treatment outcomes, Aharonovich, Amrhein, Bisaga, Nunes, and Hasin (2008) 
examined commitment language during Cognitive Behavioral Therapy (CBT) and 
cognitive functioning as predictors of treatment retention and substance use. While 
commitment language predicted substance use, cognitive functioning predicted treatment 
retention, suggesting that change language and cognitive functioning contribute 
differentially to treatment engagement and substance use after treatment. Furthermore, 
although the clinical composition of this sample was not indicated, these findings 
highlight the importance of considering the role cognitive functioning in treatment 
outcome.   
In contrast to the findings of Amrhein et al. (2003) and Aharonovich (2008), a 
study by Baer, Beadnell, Garrett, Hartzler, Wells, and Peterson, (2008) found that 
commitment language did not predict rates of substance use in homeless adolescents 
undergoing brief Motivational Interviewing. Rather, desire, ability, and reasons for 
change were prospectively predictive of substance use. Specifically, negative comments 
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about substance use behavior change were predictive of poor outcome. It should be 
noted, however, that commitment language in the Amrhein et al. (2003) study occurred 
largely during the portion of the Motivational Interviewing session in which an action 
plan for changing substance use is discussed; this component was not a part of the Baer et 
al. (2008) Motivational Interviewing sessions. Furthermore, the low intraclass 
correlations evident in ratings of commitment language in this study suggest that this 
category of change language may be difficult to characterize in adolescents. 
Nevertheless, the predictive utility of the other categories of change language suggests 
that there may be differing components of change language that are important in 
determining outcome according the sample’s characteristics.  
The assessment of change talk represents a valuable tool in understanding 
motivational processes underlying substance use behavior change and represents a 
promising alternative to self-report measures. Change language is potentially more 
proximal to behavior change in that it has direct links with the substance use outcome in 
Motivational Interviewing. Although self-report measures of motivation have 
demonstrated some utility in serious mental illness samples, an additional assessment tool 
for understanding motivational processes during Motivational Interviewing would be 
useful in informing therapists working in this population; however, it is not yet known 
whether change language can be reliably and validly measured in individuals with serious 
mental illness. Furthermore, because one of the goals in Motivational Interviewing is to 
elicit change language in the patient, the impact of symptomatology on change talk 
dimensions would be informative from the therapist’s perspective when treating patients 
with serious mental illness. 
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Rationale and Aims 
Substance use among individuals with serious mental illness is a significant 
problem associated with various negative health and societal outcomes, including 
increased severity of both disorders (Cacciola et al. 2001; Compton et al., 2005b; Ford et 
al., 2009; Kidorf et al., 2004; Mills et al., 2007; Skinstad et al., 2001; Watkins et al., 
2004), and poor substance use treatment outcomes (Barrowclough et al., 2007). 
Motivation among individuals with serious mental illness appears to be a significant 
factor in accounting for substance use treatment engagement and outcome (Barrowclough 
et al., 2006). Therefore, Motivational Interviewing is frequently used in this population as 
a standalone or to augment other substance use treatment components and has 
demonstrated effectiveness in improving treatment outcomes. Resonant with the 
framework provided by the Transtheoretical Model of Change, the Motivational 
Interviewing approach provides a client-centered therapeutic atmosphere in which the 
client’s self-efficacy and motivation with respect to changing substance use behavior are 
reinforced.  This in turn is thought to facilitate change from one stage of change to the 
next.  
The importance of the elicitation of self-motivational statements during 
Motivational Interviewing inspired researchers to examine the effect of Motivational 
Interviewing-consistent therapist behaviors on eliciting client statements regarding the 
desire, ability, need, reasons, and commitment to change (Gaume et al., 2008; Gaume et 
al., 2010; Glynn et al., 2010; Miller et al., 1993; Moyers et al., 2007; Moyers et al., 2009; 
Vader et al., 2010). The effect of change language on substance use outcomes has also 
been examined (Amrhein et al., 2003; Baer et al., 2008; Moyers, et al., 2009; Vader et al., 
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2010).  In this way, psycholinguistic analyses of patient language during Motivational 
Interviewing sessions have provided insight into motivational processes associated with 
substance use behavior change. The language categories which were predictive of 
outcome differed by study, suggesting that perhaps differing components of change 
language are important in determining outcome according to sample characteristics.  
Furthermore, low intraclass correlations of raters’ language coding in an adolescent 
sample (Baer et al., 2008) suggested that some language categories may be difficult to 
rate reliably depending on sample characteristics. Nevertheless, these studies provided 
initial support for the importance of change language in Motivational Interviewing and its 
relation to substance use outcomes among individuals undergoing MI. 
The precise nature of motivational processes during substance use treatment is not 
well understood in individuals with serious mental illness, who experience significant 
cognitive impairments and symptoms related to motivational deficits. These symptoms 
could potentially impact the client’s ability to effectively evaluate various options to 
achieve change, as well as engage in the complex set of behaviors necessary to make and 
maintain change. Furthermore, since one key component of Motivational Interviewing is 
the selective reinforcement of change language, it would be informative to understand the 
relationship between symptomatology, specifically negative symptoms, and the 
occurrence of change language among individuals with serious mental illness.  
Research has delineated the prognostic utility of change language with respect to 
substance use treatment outcomes. To this end, the analysis of language during 
Motivational Interviewing allows for a clear examination of motivation and how it is 
expressed behaviorally. To date, there have been no studies of change language among 
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individuals with serious mental illness. Furthermore, it is not clear how symptomatology 
may relate to linguistic indicators of motivation. For instance, it may be the case that 
individuals with increased negative symptoms may exhibit lessened occurrences of 
motivational language during Motivational Interviewing sessions. Also, the strength of 
change language would be expected to diminish with increasing negative symptoms.  
Change language has been reliably measured in studies that have not delineated 
the clinical characteristics of their samples; therefore, the validity and reliability of 
change talk measurement has not been established in individuals with serious mental 
illness. The interrelationships among change language components have been 
demonstrated in prior research (Amrhein, et al., 2003; Baer, et al., 2008); yet these 
relationships have not been elucidated serious mental illness samples. Furthermore, 
although the relationships of change language components to substance use treatment 
outcomes have been demonstrated in other samples, it is not clear whether change 
language has similar prognostic significance among individuals with serious mental 
illness. 
Another informative area to examine is the relationship between symptomatology 
and therapist behavior. Due to negative symptoms such as alogia and amotivation, it 
would be expected that therapists would have to exert more energy in order to engage the 
client, thus resulting in more verbosity on the part of the therapist with increasing 
negative symptoms in the patient. To date, the relationship between therapist verbosity 
and symptomatology has not been elucidated. Finally, given prior studies which found a 
link between therapists’ increased use of Motivational Interviewing-consistent behaviors 
and favorable substance use treatment outcomes (e.g., Moyers et al., 2009), the 
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examination of this association in a serious mental illness sample would provide further 
validation of the proposed causal mechanisms underlying Motivational Interviewing. 
The current study sought to characterize change language in patients with serious 
mental illness undergoing Motivational Interviewing for substance use and to examine 
the extent to which change talk could be measured reliably and validly in this sample by 
examining the relationship of change language to self-report measures of motivation to 
change. To this end, data was used from the Motivational Interviewing component of a 
randomized trial comparing the Behavioral Treatment for Substance Abuse in 
Schizophrenia (BTSAS; Bellack, Bennett, & Gearon, 2006) to treatment as usual among 
individuals with serious mental illness and co-occurring substance abuse problems.  
Specifically, psycholinguistic coding of Motivational Interviewing sessions were carried 
out and assessed for reliability. Also, measures of readiness to change, self-efficacy in 
reducing substance use, decisional balance, and processes of change measures were be 
explored for convergence with change language strength across the categories of ability 
to change, reasons for change, need for change, and commitment to change. Additionally, 
the relationship of symptomatology to change language will be examined in order to 
better elucidate the potential effect of negative symptoms on behavioral indicators of 
motivation.  
Given the overlap of negative symptoms and depressive symptoms such as 
avolition, anhedonia, and amotivation, the unique contribution of negative symptoms 
were examined. Indeed, numerous studies have found that depression and anhedonia can 
be measured independently among individuals with schizophrenia (Loas, Noisette, 
Legrand, & Boyer, 1996; Kirkpatrick, Buchanan, Breier, & Carpenter, 1994; Malla, 
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Takhar, Norman, Manchanda, Cortese, Haricharan, Verdi et al., 2002). Therefore, the 
current study will examine the unique contribution of negative symptoms to change 
language variables. 
In order to better understand patient-therapist dynamics in relation to 
symptomatology, therapist language was coded and examined in relation to negative 
symptoms. Also, given that prior studies have found increased MICO therapist behaviors 
and change language to be related to better treatment outcomes, we conducted 
preliminary examinations of these relationships. Finally, we will conduct analyses to 
examine the relationship of self-reported motivation to change and MICO therapist 
behaviors to substance use treatment outcomes. Specific hypotheses are outlined below.  
Reliability 
1. We hypothesized that psycholinguistic coding of change language would yield 
fair or better intra-class correlation coefficients (ICCs) for frequencies and 
strengths of each language category. Based on Cicchetti’s (1994) guidelines for 
evaluating interclass correlation coefficients (ICCs), the following standards were 
used: below .40, poor; .40 to .59, fair; .60 to .74, good; above .75, excellent. 
Validity 
1. Consistent with a prior study (Amrhein et al., 2003), commitment language 
should evidence underlying dimensions of desire, ability, needs, and reasons. 
Therefore, it was hypothesized that the strength of each of these language 




2. Language categories should be correlated with self-reported measures of 
readiness for change, self-efficacy, and decisional balance, and action toward 
change. Hypotheses were constructed such that each language component would 
be hypothesized to be most related to the self-report measure which shares face 
validity. Therefore, the hypotheses are as follows: 
a. The mean strengths of each language category will be significantly 
positively correlated with a total readiness score yielded from self-
reported measures of readiness for change. Additionally, language 
strengths will be negatively correlated with Precontemplation scores and 
positively correlated with Contemplation, Action, and Maintenance scores. 
b. Ability language strength will show a preferential positive correlation with 
self-efficacy measures over other measures of motivation. 
c. Reasons and need for change language will show a preferential positive 
correlation with decisional balance measures over other measures of 
motivation. 
d. Commitment language will show a preferential positive correlation with 
processes of change measures (those that assess strategies used in pursuit 
of reducing substance use) over other measures of motivation. 
e. Commitment language will be significantly positively correlated with the 
total readiness score, and each of the Contemplation, Action, and 
Maintenance scores. Also, commitment language will be significantly 




Relationship between symptomatology and change language components 
1. Negative symptoms (independent of depressive symptoms) will be significantly 
negatively correlated with the counts and mean strength of each language 
category such that greater negative symptoms will be associated with less change 
language. 
2. Negative symptoms (independent of depressive symptoms) will be significantly 
negatively correlated with verbosity, as indexed by Motivational Interviewing 
session word counts, such that greater negative symptoms will be related to less 
language output. 
Therapist behavior and patient symptomatology 
1. Negative symptoms (independent of depressive symptoms) will be significantly 
positively correlated with therapist utterances such that increased negative 
symptoms will be associated with a greater number of therapist utterances.  
a. The symptom of alogia will exhibit a preferential relationship with 
therapist utterances. 
2. Motivational Interviewing-consistent therapist behaviors will be positively 
correlated with greater change language such that increased Motivational 
Interviewing-consistent behaviors will be associated with greater change language 






Change language as a predictor of short- and long-term substance use treatment 
outcomes 
1. Short-term attendance: Increased change language strength will predict greater 
treatment session attendance during the subsequent two weeks, controlling for 
baseline substance use severity, negative symptoms, and depressive symptoms. 
This time frame was chosen to represent “short-term” outcome in order minimize 
the confounding effects of attendance at other treatment components on treatment 
engagement.  
2. Long-term attendance: Increased change language strength will predict greater 
treatment session attendance during the subsequent six months, controlling for 
baseline substance use severity, negative symptoms, and depressive symptoms. 
This time frame was chosen to represent “long-term” outcome as it is the endpoint 
of the accompanying behavioral treatment for the parent study. 
3. Short-term substance use: Increased change language strength will predict the 
absence of substance use two weeks after the Motivational Interviewing session, 
controlling for substance use severity, negative symptoms, and depressive 
symptoms.  
4. Long-term substance use: Increased change language strength will predict the 
absence of substance use six months after the Motivational Interviewing session, 





The relationship of self-reported motivation to change and short- and long-term 
substance use treatment outcomes 
1. We hypothesized that higher self-reported motivation to change would be 
significantly associated with increased short- and long-term treatment attendance. 
2. We hypothesized that higher self-reported motivation to change would be 
significantly associated with decreased short- and long-term substance use. 
Therapist MI-Consistent behavior as a predictor of short- and long-term substance 
use treatment outcomes 
1. Short-term attendance: Increased therapist MICO behaviors will predict greater 
treatment session attendance during the subsequent two weeks, controlling for 
baseline substance use severity, negative symptoms, and depressive symptoms. 
2. Long-term attendance: Increased MICO therapist behaviors will predict greater 
treatment session attendance during the subsequent two months, controlling for 
baseline substance use severity, negative symptoms, and depressive symptoms. 
3. Short-term substance use: Increased therapist MICO behaviors will predict the 
absence of substance use two weeks after the Motivational Interviewing session, 
controlling for substance use severity, negative symptoms, and depressive 
symptoms. 
4. Long-term substance use: Increased MICO therapist behaviors will predict the 
absence of substance use six months after the Motivational Interviewing session, 





Exploratory Aim: Therapist-prompted language 
1. As an exploratory aim, we proposed to examine therapist-prompted language (i.e., 
acquiescent replies by the client in response to therapist questions reflecting 
behavior change rather than explicit client statements). Therefore, inter-rater 
reliability of therapist-prompted language and all proposed exploratory analyses 








Chapter 2: Method 
Participants 
Participants for the current study were individuals who received Motivational 
Interviewing as part of a larger randomized clinical trial comparing the Behavioral 
Treatment for Substance Abuse in Schizophrenia (BTSAS; Bellack, Bennett & Gearon, 
2006)
 2
 to treatment as usual among individuals with serious mental illness and co-
occurring substance abuse. Participants were recruited from outpatient mental health 
programs operated by the University of Maryland School of Medicine Department of 
Psychiatry, Division of Community Psychiatry, and the Baltimore campus of the 
Veterans Administration Maryland Health Care System. Qualified participants were those 
who met DSM-IV criteria for both Substance Abuse or Dependence (for opiates, cocaine, 
or cannabis) and serious mental illness (schizophrenia, schizoaffective disorder, major 
depression, bipolar disorder, or other psychotic disorder). Other inclusion criteria 
included being between 18 and 55 years and being able to provide consent for 
participation. 
In this study, psycholinguistic analyses were performed on baseline Motivational 
Interviewing sessions for the 45 individuals for whom videotape of the first Motivational 
Interviewing session was available. They represented an analyzable subset of patients 
who were randomly assigned to receive BTSAS, which included a Motivational 
Interviewing session prior to the start of other treatment components. 
                                                 
2
  BTSAS components included Motivational Interviewing, social skills training, problem solving, 
coping skills training, psychoeducation regarding substance use, and contingency management. All 
components except Motivational Interviewing were conducted in group format. Patients met twice weekly 
for 52 weeks. Two additional Motivational Interviewing sessions were conducted at 3 and 6 months after 




All diagnostic assessments were conducted by clinical interviewers with at least 
Master's-level experience in psychology. Supervision was provided by doctoral-level 
psychologists. All interviews were videotaped and randomly checked for reliability. To 
address issues of uncorrected vision problems and low literacy rates in this population, all 
paper-pencil questionnaires were administered as structured interviews. Furthermore, 
paraphrasing amidst patient confusion and probing for comprehension, without biasing 
responses, were used to address difficulties with comprehension and attention. 
The first Motivational Interviewing session was conducted in the first week of 
treatment. During this session, the purpose was to identify a few key reasons to decrease 
drug use and to develop short and long-term goals for decreasing use. Participants then 
proceeded to the group component for the rest of the treatment session. Before the second 
week’s session began, patients provided a urine sample, which was screened for the 
presence of heroin, cocaine, and marijuana. 
Motivational Interviewing Session 
 The Motivational Interviewing session lasted approximately 20-35 minutes and 
was videotaped. The therapist began by discussing the patient’s progress in changing 
substance use to date, followed by a discussion of the negative consequences associated 
with use. Then, individualized feedback was given based on the patient’s endorsement 
(on a likert-type scale) of self-motivational statements during the baseline assessment. 
Specifically, discussion centered on the following University of Rhode Island Change 




1) At times my problem is difficult, but I’m working on it 
2) I have a problem and I really think I should work on it 
3) Even though I’m not always successful in changing, at least I’m working on it 
4) I wish I had some more ideas about how to solve my problem 
5) I’m actively working on my problem 
After a discussion of these items, the patient and the therapist set short-term goals 
for substance use, addressed potential obstacles, and brainstormed ways to achieve those 
goals by the next therapy session. 
The videotapes were transcribed and parsed by M.N.S. then coded for 
psycholinguistic indicators of motivation by a graduate student and a trained 
undergraduate research assistant using procedures described by Amrhein (2009, personal 
communication) and Miller, Moyers, Ernst, and Amrhein (2003). Raters were blind to 
participants’ diagnoses and to all self-report measures. 
Measures 
The measures for the current study were categorized into five domains: (1) 
screening and diagnostic assessment (2) substance use, (3) treatment engagement, (4) 









Domain Measure Purpose 
Screening and Diagnostic 
Assessment 
Structured Clinical Interview for 
DSM-IV (SCID-IV) 
To assess for psychiatric 
disorders 
Positive and Negative Syndrome 
Scale (PANSS) 
To assess positive, negative, 
and general distress symptoms 
Substance Use 
Addiction Severity Index 
To assess baseline substance 
use severity 
Urinalysis 
To screen for use of cocaine, 
heroin, or marijuana  
Treatment Engagement BTSAS attendance 









University of Rhode Island 
Change Assessment (URICA) 
To assess stages of change  





Drug Abstinence Self-Efficacy 
Scale (DASE) 
To assess the patient’s self-
efficacy in reducing drug and 
alcohol consumption 
Alcohol Abstinence Self-
Efficacy Scale (AASE) 
Decisional 
Balance 
Decisional Balance Scale –Drug  
Version (DBD) 
To assess the individual’s 
weighing of pros and cons of 
reducing drug use 
Processes 
of Change 
Processes of Change – Drug 
Version (POC-D) 
To assess the strategies 




Manual for Motivational 
Interviewing Skills Code – 
Version 2.0 (MISC 2.0) 
Therapist behavior coding 
manual for Motivational 
Interviewing session 
Change Language Coding 
DARN-C: A Training Manual 
for Coding Client Commitment 
Language 
 
Client language coding manual 
for Motivational Interviewing 
session 
 
Screening and Diagnostic Assessments  
Structured Clinical Interview for DSM-IV (SCID-IV; First, Spitzer, Gibbon, & 
Williams, 1997). The SCID-IV was administered to assess for psychiatric disorders. 
Twenty percent of videotaped interviews were randomly selected for reliability checks in 
the parent study. 
43 
 
Positive and Negative Syndrome Scale (PANSS; Kay,  Flszbein, & Opfer, 1987).  
The PANSS (see Appendix C) is a rating scale administered in interview format. It yields 
separate ratings for positive symptoms, negative symptoms, and general 
psychopathology. A depressive symptoms score was derived based on prior factor 
analytic research (Aghababian, Llorca, Bernard, & Auquier, 1999; Bell, Lysaker, Beam-
Goulet, & Millstein, 1994; Lindenmayer, Grochowski, & Hyman, 1995; Lykouras, Oulis, 
Psarros, Daskalapoulou, Botsis, Christodoulou , & Stefanis, 2000). The PANSS has good 
reliability and validity with interrater reliability ranging from .83 to .87 and Cronbach 
alpha reliabilities ranging from .73 to .83 (Kay et al., 1987). 
Substance Use 
Urinalysis. Results from analysis of urine samples for the presence of recent 
substance use was used. Urine tests were conducted as part of a contingency incentive 
system in the larger study. Urine was analyzed using the Syva Rapid Test, which 
provided results in five minutes. Assays were performed for cocaine, cannabinoids, and 
opiates twice weekly. Each test is sensitive to substance use over the prior three days. For 
the current study, the first four urinalyses of the study were used to assess for substance 
use during the first two weeks of treatment.  Long term substance use outcomes were 
indexed by the total number of clean urine samples provided by the participant 
throughout the full course of treatment.  
 Addiction Severity Index (ASI; McClellan, Kushner, Metzger, Peters, Smith, 
Grissom, et al., 1992). The ASI (see Appendix D) is a semi-structured interview 
designed to address problem areas in substance-abusing patients, including medical 
status, employment and support, drug use, alcohol use, legal status, family/social status, 
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and psychiatric status. In the current study, ASI Lifetime Substance use was used as an 
index of addiction severity. 
Treatment Engagement 
 Treatment engagement was indexed as the number of BTSAS sessions attended 
after the first Motivational Interviewing session. For short-term attendance, the number 
of days out of a possible four sessions was used. For long-term attendance, the total 
number of BTSAS sessions during the six-month period was used (a possible 52 
sessions). 
Self-Reported Motivational Measures 
 University of Rhode Island Change Assessment - Maryland (URICA-M). The 
URICA (see Appendix E) was initially developed to assess readiness to change in the 
area of smoking, but was modified for use with alcohol-dependent patients (DiClemente 
& Hughes, 1990), substance using patients, and then modified for use in individuals with 
serious mental illness (Nidecker, DiClemente, Bennett, & Bellack, 2008). Specific 
modifications included reading items aloud, simplifying questions, and shortening the 
measure to include 24 items.  
The URICA-M yields four subscales: (1) Precontemplation, (2) Contemplation, 
(3) Action, and (4) Maintenance. It also yields a total readiness score by subtracting the 
sum of the Precontemplation and Contemplation scores from the sum of the Action and 
Maintenance scores. The URICA-M has demonstrated good reliability and validity 
among individuals with serious mental illness, with Cronbach’s alphas ranging from .72-
.81 (Nidecker, et al., 2008). 
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 Cartoon Stages of Change Measure (C-SOC; Clark, Wells, Peterson, 
Jackson, & Stanton, 1996). The C-SOC (see Appendix F) was developed in order to 
assess stages of change among individuals with cognitive and reading impairments. It 
utilizes a series of cartoon panels conveying characters engaged in precontemplation, 
contemplation, action, and maintenance. The participant indicates whether each panel is 
or is not like them now, and which panel is most like them. Each stage of change is 
depicted by three cartoons, allowing for similar calculations as the URICA (one total 
score for each stage of change and a total readiness score derived by subtracting the sum 
of the Precontemplation and Contemplation scores from the sum of the Action and 
Maintenance scores). 
 Abstinence Self-Efficacy.  The Drug Abstinence Self-Efficacy Scale (see 
Appendix G) and Alcohol Abstinence Self-Efficacy Scale (see Appendix H) 
(DiClemente, Carbonari, Montgomery, & Hughes, 1994) were used to assess 
participants’ confidence in their ability to resist drugs and alcohol and the extent to which 
they feel tempted to use drugs or drink. Using a 5-point Likert-type scale, participants 
rated their self-efficacy and degree of temptation. Each scale yields eight subscales, 
indicating self-efficacy and temptation in four contexts (Negative Affect, Social/Positive 
Influences, Physical and Other Concerns, and Withdrawal and Urges). The ASE had 
excellent internal consistency among those with serious mental illness and substance use 
disorders, with a Cronbach alpha of 0.91.  
 Decisional Balance Scales.  The drug version of the Decisional Balance Scale 
(see Appendix I) (Velicer, DiClemente, Prochaska, & Brandenburg, 1985) was used to 
measure the participant’s perceived costs and benefits of using drugs and drinking 
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alcohol. Additional items were added to reflect frequently encountered situations faced 
by clients in this population (e.g., court control of children, release from jail being 
contingent on abstinence, eviction from an apartment). Items are rated on a 5-point 
Likert-type scale. Internal consistency in individuals with serious mental illness and 
substance use disorders was been found to be 0.85 (Nidecker et al., 2008). 
 Process of Change.  The drug version of the Processes of Change scale (see 
Appendix J) (DiClemente, Carbonari, Addy, & Velasquez, 1996) was used to assess the 
experiential and behavioral processes that participants use in order to resist the use of 
drugs. The 20-item measure asks participants to rate on a 5-point Likert-type scale the 
frequency with which they use various strategies. The scale yields two subscales, 
Experiential and Behavioral, which have demonstrated good internal consistency among 
serious mental illness and substance use disordered individuals (Cronbach alphas = 0.76 
and 0.81, respectively). 
Change Language and Therapist Language Coding 
Manual for Motivational Interviewing Skills Code – Version 2.0 (MISC 2.0; 
Williams, Moyers, Ernst, & Amrhein, 2003).  The training of coders and coding 
procedures for categorizing therapist behaviors during Motivational Interviewing sessions 
was performed according to procedures outlined in the MISC 2.0 (see Appendix K), 
which were initially designed to assist in performing quality assessment from the 
videotapes and audiotapes of Motivational Interviewing sessions. One of the recent uses 




DARN-C (Desire, Ability, Reasons, Need, and Commitment): A Training 
Manual for Coding Client Commitment Language (Amrhein, 2009). Additional 
guidance for the training of coders and the coding procedures for categorizing client 
language during the Motivational Interviewing sessions were performed according to 
procedures outlined in the DARN-C manual (see Appendix L). This coding procedure 
allows for a richer assessment of client language than the MISC 2.0, and contains 
additional material to consider in the training of coders. Because this manual only 
addresses client language, the MISC 2.0 was used as an adjunct for therapist behavior 
coding and for general coder training procedures. 
 Videotape transcription and coding.  Each client was videotaped during each of 
three Motivational Interviewing sessions. Due to significant participant attrition from the 
study, the current study used only the first session. The sessions lasted from 20-30 
minutes. Videotapes were labeled with the participant number, session number, and the 
therapist conducting the session. 
 The videotapes were transcribed without knowledge of the identity or outcome 
measures of the clients and blind to the diagnostic status of the clients. The transcription 
was then parsed into utterances, which are those statements which represent a full thought 
either in response to a therapist’s question, or those that are unsolicited and said 
spontaneously. Although the Motivational Interviewing Skill Code, version 2.0 manual 
indicates that acquiescent replies to the therapist’s statements should be omitted, such 
replies were coded and analyzed, for the purpose of examining some supplementary 
analyses given the severe verbal and cognitive deficits in this population. Therefore, the 
48 
 
data was analyzed with and without the inclusion of acquiescent replies (see Appendix B 
for re-analysis of the data considering acquiescent replies). 
 Codable utterances are complete thoughts that can be characterized as language 
reflecting commitment, desire, ability, need, reasons, and taking steps toward substance 
use reduction or abstinence. An utterance ends upon the completion of a thought or when 
another speaker begins speaking. 
After being categorized, each statement was assigned a strength and valence value 
from -5 to +5. Ratings of “0” are given for those statements that do not indicate any 
intention to move toward or away from change. Negative values indicate statements that 
support continued substance use, while positive values indicate statements that support 
reduction or discontinuation of use.  Strength value is determined by the content, tone, or 
context of each utterance (MISC 2.0, 2003). The stronger the statement, the higher the 





“I guarantee that I can stop using.” +5 
“I plan to cut down my drinking.” +3 
“I don’t intend to stop drinking.” -4 
Desire  
“For the most part, I want to quit.” +2 
“I kind of enjoy drinking.” -1 
“Pretty much, yes, I like drinking.” -2 
Ability  
“I am positive that I could quit.” +5 
“I have a little trouble sticking to things” -1 
“It’s just impossible.” -5 
Need  
“I absolutely have to stop using cocaine.” +5 
“I guess I need to cut down.” +1 




“I’ll be in trouble if I turn in another positive urine.” +4 
“I guess I’d be a bit healthier if I stopped drinking.” +1 
“I probably would have trouble sleeping without it.” -2 
Taking Steps  
“I stayed away from friends who I know use all week.” +3 
“I didn’t take my Antabuse.” -3 
“I completely blew it this week trying to drink.” -5 
 
Therapist behavior coding was consistent with studies examining Motivational 
Interviewing-consistent and –inconsistent behaviors (e.g., Gaume, et al., 2008; Moyers et 
al., 2007). Specifically, the therapist behaviors of affirming, emphasizing personal 
choice, seeking permission to give advice/information, and offering support are 
considered Motivational Interviewing-consistent behaviors. Advising without permission, 
confronting, directing, raising concern without permission, and warning are considered 
Motivation Interviewing-inconsistent behaviors. In order to assess therapist verbosity, the 
number of utterances during the session was tabulated. 
Training and reliability of raters. Two raters were utilized who were 
extensively trained in the categorization and rating of client utterances, with a total 
training time of about 42 hours.  A stepped learning process was utilized to train coders. 
After training on the types of utterances, a testing phase began, wherein examples of 
utterances were given to raters to categorize client change language categories. After 
each rater was able to classify 90% of the statements correctly, additional examples were 
given to code for the strength of statements. After an ICC of at least .85 was reached, six 
transcripts that were not used for the purposes of this study were coded and assessed for 
reliability.  A Kappa reliability coefficient was used to assess rater agreement for the 
categorization of client and therapist utterances across all training transcripts. A Kappa of 
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.82 was achieved, indicating “excellent” agreement. ICCs were used to assess agreement 
for strength ratings. Each category for each transcript was treated as a data point in the 
assessment of reliability. For instance, the mean ratings for desire, ability, reasons, 
readiness, need, and commitment were treated as six separate data points. Therefore, 
across the six training transcripts, there were 36 possible data points across which to 
assess rater reliability. An ICC of .76 was reached, indicating excellent agreement. After 
the training phase, each coder rated all transcripts. Bi-weekly meetings were held to 
discuss scoring difficulties. Additionally, the current author was available for questions 
which arose in between meetings. Both coders were kept informed of each others’ 





Chapter 3: Results 
 
Descriptive Data 
Of the available Motivational Interviewing tapes (n = 55), 45 were audible and 
complete (i.e., some of the VHS tapes were of poor quality due to wear and some did not 
capture the full MI session due to equipment failure); these tapes constituted the 
Motivational Interviewing sessions used in this study. Descriptives for demographic data 
are presented in Table 1. Clinical characteristics, including psychiatric disorders, PANSS 
symptoms, and substance use variables are presented in Table 2. 
 
Table 1 
Descriptives for demographic data. 
Demographic Variable  
Gender (male) 58% 






Mean years (SD) 11.6 (1.8) 
















Clinical characteristics of the sample. 
Psychiatric Disorders  Percentage  
Bipolar  51.1 
Major Depressive 17.8 
Schizoaffective  15.6 
Psychosis Not Otherwise Specified 11.1 
Schizophrenia 2.2 
Post Traumatic Stress/ Other Anxiety 2.2 
PANSS Symptoms  Mean (SD) 
Negative  12.1 (4.7) 
Positive  12.4 (4.2) 
General 28.7 (5.7) 
Substance Use Disorders Percentage  
Drug Abuse 86.7 
Drug Dependence 48.9 
Alcohol Abuse 0.0 
Alcohol Dependence 15.6 






Reliability of Client Language Coding 
The full sample of 45 tapes was coded by two independent raters (a Master’s level 
graduate student and an undergraduate research assistant). Using the Motivational 
Interviewing therapy session transcript, coders identified the occurrence of each of 6 
client change language categories (Desire, Ability, Reasons, Readiness, Need, and 
Commitment) and gave each change language statement a strength rating.  
Frequency and strength ratings were assessed for reliability across using Intraclass 
Correlation Coefficients (ICCs; Shrout & Fleiss, 1979). Note that the ability to calculate 
ICCs, and the magnitude thereof, are heavily influenced by base rates of occurrence due 
to low power to assess agreement. Therefore, lower base rates are associated with lower 
reliability. Desire, Ability, Reasons, and Commitment language occur at least once in a 
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high percentage of the sample (49%-100%); however, Readiness language occurs at least 
once in a relatively lower percentage of the sample (7%). Furthermore, although Need 
language occurs at least once in 20% of the sample, this percentage drops to 0% when 
considering its occurrence at least two times in the sample. Low base rates greatly 
restricted the range of these variables, and in turn affected the reliability and 
interpretability of any results involving Readiness and Need language.  Therefore, we 
were not able to conduct analyses involving these two variables. The base rates of client 
















Desire  49% 13% 13% 
Ability 100% 33% 33% 
Reasons 98% 98% 98% 
Readiness 7% 2% 2% 
Need 20% 0% 0% 
Commitment 88.9% 86.7% 66.7% 
 
Although no specific hypotheses were delineated regarding ICCs, we used the 
guidelines outlined by Cicchetti (1994), who suggested that reliability coefficients below 
.40 are poor, those between .40 and .59 are fair, those between .60 and .74 are good, and 
those .75 and above are excellent. These guidelines have been used in prior studies 
examining change language during Motivational Interviewing (e.g., Baer, et al., 2008; 
Moyers, 2009).  
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Reliability of frequency ratings. According to the aforementioned guidelines, 
ICCs for Desire (.75), Ability (.83), Reasons (.82), and Commitment (.89) were excellent 
according to Cicchetti’s (1994) guidelines. The minimum, maximum, mean, and ICCs of 
frequency ratings are presented in Table 4. 
 
Table 4 
Summary data and ICCs for mean client language frequency ratings. 
Summary Variable Min Max M SD ICC 
Desire  0.00 7.00 0.98 1.47 0.75 
Ability 0.00 9.00 2.18 2.70 0.83 
Reasons 0.00 27.00 12.91 6.98 0.82 
Commitment 0.00 19.00 3.69 4.68 0.89 
Note. Min = Minimum mean of coders’ ratings, Max = Maximum of mean of coders’ 
ratings; means and standard deviations calculated on mean of coders’ ratings. 
 
Reliability of strength ratings. The strength of Ability (.66) and Reasons (.66) 
language qualified as having good inter-rater agreement according to Cicchetti’s (1994) 
guidelines. The reliability of Desire and Commitment language strength (.03 and .22, 
respectively) did not reach an acceptable level, evidencing poor agreement. Therefore, 
subsequent analyses involving the strength of Desire and Commitment language were not 
able to be performed, as any yielded findings would have been unreliable. Summary data 
and ICCs for mean client language strength ratings are presented in Table 5. 
 
Table 5 
Summary data and ICCs for mean client language strength ratings. 
Summary Variable Min Max M SD ICC 
Desire 1.00 5.00 4.20 1.09 0.03 
Ability -5.00 5.00 -1.71 2.13 0.66 
Reasons 1.60 5.00 4.38 0.76 0.66 
Commitment 1.00 5.00 3.63 1.01 0.22 
Note. Min = Minimum mean of coders’ ratings, Max = Maximum of mean of coders’ 




 An issue that affected the ability to assess language strength reliability was that of 
missing data cells. When clients did not make a statement belonging to a certain language 
category, a frequency of zero was assigned. In contrast, strength ratings are missing in 
this case, as a strength rating cannot be designated for utterances which did not occur. 
This results in missing data cells. Therefore, strength ratings are not able to be provided 
for a subset of the sample in categories which the client did not make a statement. This 
resulted in a drastic reduction in sample size for many of the proposed analyses. Due to 
this issue and to the low reliabilities for strength ratings, we conducted all analyses using 
frequency language. We used this approach because change language frequencies yielded 
higher reliabilities and contained no missing data cells, thus allowing the use of all data 
and for more power to detect effects. Furthermore, since Amrhein’s (2002) findings, 
which found effects using change language strength, another research group (see Moyers, 
2009) has been unable to yield reliable strength ratings and has used frequency ratings 
instead. Proposed analyses involving change language strength for Ability and Reasons 
(categories which achieved acceptable reliability and did not present with the issue of 
missing cells) are presented at the end of the Results section.  
Inter-relationships among change language frequency categories.  Due to 
aforementioned issues with yielding reliable strength ratings, frequency ratings were used 
to examine whether the inter-relationships among change language categories reflect 
patterns of prior research which found that (1) all language categories were significantly 
correlated with Commitment language, and (2) Commitment language reflects the 
underlying dimensions of Desire, Ability, Need, and Reasons change language (Amrhein, 
et al., 2003; Baer, 2003). That is, each underlying dimension exhibited unique 
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relationships with Commitment language. Therefore, each underlying dimension should 
account for unique variance in Commitment language, with each language category 
exhibiting significant positive partial correlations with commitment strength. For reasons 
stated earlier, the unique relationship of Need and Readiness language to Commitment 
language was not able to be examined. 
Zero-order intercorrelations of all language variables are presented in Table 6. 
Commitment language frequency was significantly positively correlated with Desire, 
Ability, and Reasons frequency, indicating that increased statements during the 
Motivational Interviewing session related to the client’s desire, self-efficacy, and reasons 
for reduction/abstinence were related to increased statements of commitment. Partial 
correlations with Commitment language frequency revealed that Reasons (pr = .31, p < 
.05) and Ability language frequency (pr = .63, p < .001) accounted for unique variance in 
Commitment language frequency. The partial correlation with Desire was not significant 
(pr = .22, p > .05); therefore, prior findings that Desire, Ability, Need and Reasons 
strength underlie Commitment was only partially supported. The frequency of statements 
related to reasons and perceived ability to reduce/stop substance use accounted for unique 
variance in the frequency of commitment language. 
 
Table 6 
Intercorrelations of language variables. 




Ability --- --- .06 .70
*** 
Reasons --- --- --- .30
* 
Commitment --- --- --- --- 
+
p < .10, 
*
p < .05, 
**
p < .01, 
***





Relationship of Change Language Frequencies with Self-Report Measures of 
Motivation.  We hypothesized that each change language component would 
demonstrate significant correlations with self-reported general motivation, as assessed by 
the URICA and C-SOC. To test this hypothesis, we conducted zero-order correlations of 
change language frequency with the URICA and C-SOC.  There were no significant 
correlations, suggesting that change language frequency as measured by patient 
statements within therapy sessions is not associated with general self-reports of 
motivation to reduce/stop substance use.  These results are presented in Table 7. 
 
Table 7 
Correlations of URICA and C-SOC with change language frequency. 
 Desire Ability Reasons Commitment 
Readiness to Change     
URICA Total -.15 .06 .15 -.05 
URICA Precontemplation .02 -.17 -.21 .00 
URICA Contemplation -.01 .08 .23 .14 
URICA Action -.03 .05 .14 -.09 
URICA Maintenance -.27 -.13 -.13 -.18 
C-SOC Total .22 .11 .11 -.03 
C-SOC Precontemplation -.27 -.14 .02 -.04 
C-SOC Contemplation -.17 -.17 .00 .08 
C-SOC Action -.01 -.07 .15 -.08 
C-SOC Maintenance .22 .08 .22 .06 
+
 p < .10,
*
p < .05, 
**
p < .01, 
***
p < .001. 
 
We also hypothesized that each change language component would demonstrate a 
preferential positive correlation with the self-report measure of motivation which shared 
face validity. To test this hypothesis, we conducted correlations between Desire, Ability, 
Reasons, and Commitment frequency and self-reported drug and alcohol abstinence self-
efficacy, decisional balance, and processes of change. If these correlations were 
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significant, then tests of preferential correlations would be conducted. For the purposes of 
these analyses, the total score of each self-report measure was used. Contrary to 
expectations, Desire, Ability, Reasons, and Commitment frequency were not significantly 
correlated with self-report measures of readiness for change (URICA and C-SOC), drug 
and alcohol abstinence self-efficacy (DASE and AASE), decisional balance, drug version 
(DBD), and processes of change, drug version (POC-D) (all ps > .05). Thus, there was no 
evidence of any preferential relationships of the frequency of any change language 
category and any self-report of motivation. These results are presented in Table 8.  
 
Table 8 
Correlations of DASE, DBD, and POC-D with change language frequency. 
 Desire Ability Reasons Commitment 
Abstinence Self-Efficacy     
DASE Total .18 .11 .09 .11 
AASE Total .20 .23 .4 .04 
Decisional Balance - Drugs 
DBD - Pros -.21 -.24 .02 -.21 
DBD - Cons -.05 -.20 .11 -.16 
Processes of Change     
POC-D -.06 .05 .15 .04 
+
p < .10, 
*
p < .05, 
**
p < .01, 
***
p < .001. 
 
Negative Symptoms and Client Language  
Negative symptoms and change language. We hypothesized that negative 
symptoms (independent of depressive symptoms) would be significantly negatively 
correlated with the frequencies of each language category such that greater negative 
symptoms would be associated with less change language frequency. Thus, partial 
correlations were conducted between negative symptoms and change language 
frequencies (controlling for depressive symptoms).  
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Our hypothesis was not supported. Negative symptoms were not significantly 
correlated with any change language category frequencies (ps > .05). Therefore, the 
amount of change language generated during Motivational Interviewing was not related 
to clients’ negative symptoms
3




Correlations of PANSS negative symptoms and change language frequencies and partial 
correlations (controlling for depressive symptoms). 
  Language Category Frequency 
 Mean (SD) Desire Ability Reasons Commitment 
Zero-order 1.73 (.67) -.09 -.15 -.24 -.10 




p < .10, 
*
p < .05, 
**
p < .01, 
***
p < .001. 
 
Negative symptoms and client verbosity. We predicted that negative symptoms 
(independent of depressive symptoms) would be significantly negatively correlated with 
client verbosity. We also predicted that the symptom of alogia would exhibit a 
preferential relationship with client verbosity. Therefore, we conducted separate Pearson 
partial correlations (controlling for depression) between client verbosity and negative 
symptoms. We also did so for the PANSS item which reflected alogia (i.e., “lack of 
spontaneity and flow of conversation”). Client verbosity was not related to negative 
symptoms (pr
 
= -.08, p = .60) or to alogia (pr
 
= -.24, p = .11); therefore, neither increased 
                                                 
3
  These correlations remained non-significant regardless of whether or not depressive symptoms 
were also included in the analyses.  
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negative symptoms nor increased alogia was associated with less speech generation 
during MI
4
. These results are presented in Table 10. 
Table 10 
Zero-order and partial correlations (controlling for depressive symptoms) of PANSS 










Alogia Zero-order -.09 
Alogia Partial -.24 
+
p < .10, 
*
p < .05, 
**
p < .01, 
***
p < .001. 
 
Therapist Behavior, Negative Symptoms, and Change Language 
Therapist verbosity and PANSS negative symptoms. We hypothesized that 
negative symptoms (independent of depressive symptoms) would be significantly 
positively correlated with therapist verbosity. Therefore, zero-order and Pearson partial 
correlations (controlling for depressive symptoms) between negative symptoms and 
therapist verbosity were conducted. Negative symptoms were not significantly related to 
therapist verbosity (pr
 
= .15, p = .34), even when controlling for depressive symptoms (pr
 
= .12, p = .43).  
We also hypothesized that the PANSS item reflecting the negative symptom of 
alogia would exhibit a preferential positive relationship with therapist verbosity over 
other symptoms. This hypothesis was not supported, as alogia was not significantly 
related to therapist verbosity (pr
 
= .15, p = .34), even when controlling for depressive 
symptoms (pr
 
= .15, p = .32).  Contrary to our hypotheses, these findings indicate that 
                                                 
4
  These correlations remained non-significant regardless of whether or not depressive symptoms 
were also included in the analyses.  
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neither greater negative symptoms nor the symptom of alogia was associated with more 
speech generation in therapists during MI
5
.  
Motivational Interviewing-consistent (MICO) behaviors and change 
language frequency. We hypothesized that MICO behaviors by the therapist would be 
positively correlated with greater change language frequencies in clients.  In order to test 
this hypothesis, the frequency of the 13 MICO behaviors (i.e., Advise with permission, 
Affirm, Emphasize Control, Facilitate, Filler, Giving Information, Open Question, Raise 
concern with permission, Simple reflection, Complex reflection, Reframe, Support, 
Structure) was averaged across both raters. The minimum and maximum frequency of 
each therapist behavior across participants, mean of the frequency of MICO behaviors, 
and the ICC across raters are presented in Table 11.  
To examine the relationship between Motivational Interviewing-consistent 
(MICO) therapist behaviors and client change language, we conducted correlations 
between the number of MICO behaviors and change language frequencies. MICO 
behaviors were significantly positively correlated with Reasons language frequency (r = 
.53, p < .001). Contrary to our prediction, there were no other significant correlations (all 
ps > .05). These results indicate that therapists’ increased use of MI-consistent behaviors 
were associated with greater frequency of Reasons language from the patient, but 
therapist Motivational Interviewing-consistent behaviors were not related to patients’ 





                                                 




Summary data and ICC for Motivational Interviewing-Consistent (MICO) therapist 
behaviors and correlations of MICO behaviors with change language strength and 
frequency. 
      Language Frequency 
MICO 
Behaviors 
Min Max M SD ICC 
D A R C 
 





Note. Min = Minimum mean of coders’ ratings, Max = Maximum of mean of coders’ 
ratings; means and standard deviations calculated on mean of coders’ ratings. D = Desire; 
A = Ability; R = Reasons; C = Commitment. 
+
p < .10, 
*
p < .05, 
**
p < .01, 
***
p < .001. 
 
 
Change Language Frequency as a Predictor of Substance Use Treatment Outcomes 
 We examined the relationship of change language frequency to short- and long-
term treatment attendance and substance use, above and beyond depressive symptoms, 
negative symptoms, and substance use severity. Short-term outcomes were defined as the 
two weeks of treatment after the Motivational Interviewing session. There were four 
possible sessions clients could attend during this time. Long-term attendance was defined 
as the full length of treatment, which was attendance at a possible 52 treatment sessions 
in the BTSAS sessions that followed the MI. Also, urinalyses performed at BTSAS 
sessions indicated the presence or absence of the client’s goal drug (i.e., cocaine, heroin, 
or marijuana). In order to examine whether increased change language frequency would 
predict short and long term substance use treatment outcomes, we conducted four 
separate hierarchical regression analyses (with short- and long-term attendance and short- 
and long-term substance use as criterion variables), controlling for negative symptoms, 
depressive symptoms, and substance use severity (as indexed by the ASI Lifetime 
Substance Use). Negative symptoms, depressive symptoms, and substance use severity 
were entered into the first step and change language frequencies for Desire, Ability, 
Reasons, and Commitment were entered into the second step. 
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Short-term treatment attendance. The overall model was not significant 
[F(7,32) = 1.78, R
2
 = .28, p = .13]. As revealed by the regression coefficients significance 
tests, none of the change language categories uniquely predicted short-term treatment 
attendance (all ps > .05).  
Short-term substance use. The overall model was not significant [F(7, 32) = 
1.54, R
2
 = .25,  p = .19]. As revealed by the regression coefficients significance tests, 
none of the change language categories uniquely predicted substance use (all ps > .05). 
These findings indicate that change language frequencies did not predict increased short-
term substance use after the Motivational Interviewing session. 
Long-term treatment attendance. The overall model was significant [F(6,37) = 
2.36, R
2
 = .37, p < .05]. An examination of regression coefficients revealed that Ability 
language frequency uniquely predicted long-term treatment attendance (β = .52, t(32) = 
2.38, sr
2
 = .11, p < .05). These results indicate that greater frequency of statements 
related to perceived ability to reduce/stop substance use during Motivational Interviewing 
uniquely predicted a greater amount of sessions clients attended above and beyond 
depressive symptoms, negative symptoms, and substance use severity. Additionally, 
increased depressive symptoms (β = .42, sr
2
 = .14, p = .01) and substance use severity (β 
= .33, sr
2
 = .09, p = .04) predicted increased long term treatment attendance in the final 
model. These results are presented in Table 12. We also considered the fact that 
Motivational Interviewing sessions occurred at different intervals after the first BTSAS 
treatment session. Therefore, we ran the same analyses considering only those after the 
Motivational Interviewing session, rather the total amount of sessions. These results did 
not change when considering only those sessions after the Motivational Interview.  
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Long-term substance use. The omnibus ANOVA indicated that the full model 
was significant [F(7, 32) = 2.51, R
2
 = .36, p < .05]. An examination of regression 
coefficients revealed that Ability language frequency approached significance as a 
significant unique predictor (β = .42, sr
2
 = .07, p = .07) of substance use after the 
Motivational Interviewing session. These results are presented in Table 13. These results 




Hierarchical regression analysis of change language frequency predicting long term 
treatment attendance. 





    
Negative symptoms 2.74 4.50 .00 .55 
Depressive symptoms
* 
1.38 .66 .10 .04 
Substance Use Severity
+ 
10.61 5.60 .08 .07 
Step 2
*     
Negative symptoms 4.40 4.26 .02 .31 
Depressive symptoms* 1.86 .69 .14 .01 
Substance Use Severity
*
  11.28 5.31 .09 .04 
Ability
* 
2.91 1.22 .11 .02 
Desire -2.14 1.77 .03 .24 
Reasons -.32 .32 .02 .32 
Commitment -.44 .84 .01 .60 
+









Hierarchical regression analysis of change language frequency predicting long term 
substance use (as indexed by the number of clean urinalyses). 




**     
Negative symptoms -6.10 4.55 .04 .19 
Depressive symptoms
** 
1.95 .67 .17 .01 
Substance Use Severity 8.07 5.66 .04 .16 
Step 2
**     
Negative symptoms -4.44 4.62 .02 .34 
Depressive symptoms
** 
2.44 .75 .22 .00 
Substance Use Severity 8.22 5.76 .04 .16 
Ability
+ 
2.51 1.33 .07 .07 
Desire -1.99 1.92 .02 .31 
Reasons .13 .34 .00 .71 
Commitment -.46 .91 .00 .62 
+
p < .10, *p < .05, **p < .01, ***p < .001. 
 
The Relationship of Self-Report Measures of Motivation to Substance Use 
Treatment Outcomes 
 Correlations between self-report measures of motivation and treatment outcomes 
are provided in Table 14.  Increased readiness to change scores on the C-SOC were 
significantly associated with increased short-term attendance and clean urines. There 
were no other significant correlations. We then examined the relationship of readiness to 
change as indexed by the C-SOC to short-term treatment attendance and substance use, 
above and beyond depressive symptoms, negative symptoms, and substance use severity.  
Therefore, we conducted two separate hierarchical regression analyses (with short-term 
attendance and substance use as criterion variables), above and beyond negative 
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symptoms, depressive symptoms, and substance use severity (as indexed by the ASI 
Lifetime Substance Use). Negative symptoms, depressive symptoms, and substance use 
severity were entered into the first step and C-SOC total score was entered into the 
second step. 
 Short-term attendance. The overall model was significant [F(4,39) = 4.41, R2 = 
.34, p < .01]. An examination of regression coefficients indicated that C-SOC scores 
uniquely predicted  short-term treatment attendance (β = .34, t(39) = 2.44, sr2 = .11, p < 
.05). These results indicate that greater self-reported readiness to change, as indexed by 
the C-SOC, uniquely predicted better short-term treatment attendance above and beyond 
depressive symptoms, negative symptoms, and substance use severity.  
 Short-term substance use. The overall model was significant [F(4,39) = 4.58, R2 
= .59, p < .01]. An examination of regression coefficients indicated that C-SOC scores 
uniquely predicted  short-term substance use (β = .33, t(39) = 2.34, sr2 = .10, p < .05). 
These results indicate that greater self-reported readiness to change, as indexed by the C-
SOC, uniquely predicted less substance use in the short-term above and beyond 


















Correlations between self-report measures of motivation tto change and substance use 
treatment outcomes. 








Readiness to Change 




** -.02 .22 
Abstinence Self-Efficacy 
DASE Total -.04 .07 -.10 -.00 
AASE Total .10 .13 -.08 .08 
Decisional Balance - Drugs 
DBD - Pros -.15 -.07 -.10 -.06 
DBD - Cons .03 .21 -.08 .10 
Processes of Change 
POC-D -.00 .28 -.19 .12 
*p < .05; 
**
p < .01; Note: “Substance use” is defined as number of clean urines 
 
The Relationship of MI-Consistent Therapist Behaviors to Substance Use 
Treatment Outcomes 
 Correlations between MICO therapist behaviors and treatment outcomes are 
provided in Table 15.  We examined the relationship of MICO therapist behaviors to 
short- and long-term treatment attendance and substance use, above and beyond 
depressive symptoms, negative symptoms and substance use severity.  
 In order to examine whether increased MI-consistent therapist behaviors would 
predict short and long term substance use treatment outcomes, we conducted four 
separate hierarchical regression analyses (with short- and long-term attendance and 
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substance use as criterion variables), above and beyond negative symptoms, depressive 
symptoms, and substance use severity (as indexed by the ASI Lifetime Substance Use). 
Negative symptoms, depressive symptoms, and substance use severity were entered into 
the first step and total MICO therapist behaviors was entered into the second step. 
  MICO therapist behaviors did not significantly predict outcomes in any of the 
four regression models (all ps > .05). These results indicate that MICO therapist behavior 
did not significantly predict short- or long-term attendance or substance use. 
 
Table 15 
Correlations between MICO therapist behaviors and substance use treatment outcomes. 








-.19 -.29 -.11 -.19 
Note: “Substance use” is defined as number of clean urines 
 
Proposed Analyses Using Strength Ratings 
Relationship of Change Language Strength with Self-Report Measures of 
Motivation 
Change language strength and readiness for change. We hypothesized that the 
mean strengths of each language category would be significantly positively correlated 
with self-reported total motivation scores yielded from the URICA and the C-SOC. We 
also hypothesized that change language strengths would be negatively correlated with 
Precontemplation scores and positively correlated with Contemplation, Action, and 
Maintenance scores. Correlations of self-reported readiness for change scales with 
language strength are presented in Table 16. Due to the inability to use strength ratings 
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for Desire, Readiness, Need, and Commitment, only hypotheses related to Ability and 
Reasons strength were able to be examined. 
Contrary to our hypotheses, there were no significant correlations of the strength 
of Desire and Ability language with self-reported readiness to change, Precontemplation, 
Contemplation, Action, or Maintenance subscales of the URICA and the C-SOC. These 
results indicate that client statements regarding self-efficacy and reasons to reduce/stop 
substance use did not relate to self-reported measures of readiness to change or any of the 
stages of change. 
Preferential associations between change language strength and self-reported 
readiness to change, self-efficacy, decisional balance, and processes of change. We 
hypothesized that each change language component would demonstrate a preferential 
positive correlation with the self-report measure of motivation which shared face validity. 
For the purposes of these analyses, the total score of each self-report measure was used. 
Due to the aforementioned issues with strength data available for analyses, we were only 
able to examine the hypothesized preferential relationships of Ability and Reasons 
language strength with self-reported self-efficacy and decisional balance, respectively. 
We first conducted zero-order correlations of Ability and Reasons language strength with 
self-reported drug abstinence self-efficacy, alcohol abstinence self-efficacy, decisional 
balance (pros and cons subscales), and processes of change (DASE, AASE, DBD-Pros, 
DBD-Cons, and POC-D, respectively). We then assessed preferential correlations using 
tests of the equality of correlations outlined by Cohen, Cohen, Aiken, and West (2002); 
however, it should be noted that this study did not have enough power to detect medium 
effect size differences between correlations. Therefore, the lack of significant differences 
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among correlations should be interpreted in this context. The correlations of change 
language strength and assessments of readiness to change, self-efficacy, decisional 
balance, and processes of change are presented in Table 16. 
Ability language strength and self-efficacy. We predicted that Ability language 
strength would show a preferential positive correlation with self-efficacy measures (over 
other measures of motivation). The correlation of self-reported drug and alcohol 
abstinence self-efficacy scores (DASE and AASE) with Ability language strength were 
.52 and .55 (ps < .01), respectively. The correlation of the Drug Decisional Balance Pros 
scale (DBD-Pros) with Ability language strength was -.44 (p < .05). The correlations of 
Ability language strength with the total readiness for change (as indexed by the URICA 
and the C-SOC), Drug Decisional Balance Cons (DBD-Cons), and the Processes of 
Change – Drug (POC-D) total scores were not significant (ps > .05).   
Although the correlations Ability language strength with DASE and AASE total 
scores was significantly greater than that with the URICA, C-SOC, DBD-Cons and POC-
D total scores, the magnitude of the correlation did not differ significantly from the 
correlation with the DBD-Pros score. Therefore, Ability language strength during 
Motivational Interviewing did not preferentially correlate with self-reported self-efficacy 
to reduce or stop drug use, but did evidence a higher correlation than with other self-
report measures of motivation. Again, given sufficient power, the correlation magnitude 
of Ability language with self-efficacy measures (r =.52 and r = .55) may have been 
significantly different from that with decisional balance measures (r = -.44).  
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Reasons language strength and decisional balance. We predicted that Reasons 
language strength would show a preferential positive correlation with the Decisional 
Balance Pros and Decisional Balance Cons scales over other measures of motivation.  
 Reasons strength did not demonstrate a significant correlation with the 
Decisional Balance – Drug scales. Therefore, contrary to our hypothesis, the strength of 
statements indicating Reasons for change during Motivational Interviewing was not 
preferentially related to self-reports of pros and cons of drug use over other assessments 
of motivation. 
Table 16 
Correlations of readiness to change measures with change language strength. 
 A 
(n = 29) 
R 
(n = 44) 
Readiness to Change   
URICA Total .05  .14 
URICA Precontemplation -.31 -.09 
URICA Contemplation .16 .21 
URICA Action .06 .05 




C-SOC Precontemplation -.25 .07 
C-SOC Contemplation -.22 .06 
C-SOC Action .15 .14 
C-SOC Maintenance .29 .21 





Decisional Balance - 
Drugs 
  
DBD - Pros -.44* .19 
DBD - Cons -.20 .14 
Processes of Change   
POC-D .31 .23 
Note. Sample size on which each correlation was conducted indicated in parentheses. A = 
Ability; R = Reasons. Shaded cells indicate hypothesized correlations, with gridded cells 
indicating hypothesized preferential correlations. 
+






Negative Symptoms and Client Language  
Negative symptoms and change language strength. We hypothesized that 
negative symptoms (independent of depressive symptoms) would be significantly 
negatively correlated with the mean strengths of each language category such that greater 
negative symptoms would be associated with less change language strength. Thus, zero-
order and partial correlations (controlling for depressive symptoms) were conducted 
between negative symptoms and change language strengths. These results are presented 
in Table 17. 
 
Table 17 
Correlations and partial correlations (controlling for depressive symptoms) of negative 
symptoms with change language strength. 
 Desire Ability Reasons Commitment 
Negative Symptoms -.24 -.30 -.18 -.22 
Negative Symptoms (partialled) -.25 -.39
* -.19 -.21 
+
 p < .10,
 *
p < .05, 
**
p < .01, 
***
p < .001. 
 
Our hypothesis was partially supported. Negative symptoms demonstrated a 
significant negative partial correlation with Ability strength (n = 29, r = -.39, p < .05), but 
not Reasons strength (n = 44, r = -.19, p = .12). These results indicate that more negative 
symptoms are related to lower strength of statements related to ability to reduce/stop drug 
use among those who made ability statements.  
Motivational Interviewing-consistent (MICO) behaviors and change 
language strength. We hypothesized that MICO behaviors would be positively 
correlated with greater change language strength.  To examine the relationship between 
(MICO) therapist behaviors and client change language strength, we conducted 
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correlations between the number of MICO behaviors and Ability and Reasons strength. 
MICO behaviors were not significantly correlated with the strength of Ability (r = -.12, p 
> .05) or Reasons (r = -.12, p > .05) language. Contrary to predictions, these results 
indicate that therapists’ increased use of MI-consistent behaviors is not associated with 
the strength of any change language category.  
Change Language Strength as a Predictor of Substance Use Treatment Outcomes 
 We examined the relationship of Reasons and Ability change language strength to 
short- and long-term treatment attendance and substance use, above and beyond 
depressive symptoms, negative symptoms and substance use severity. In order to 
examine whether increased change language frequency would predict short and long term 
substance use treatment outcomes, we conducted four separate hierarchical regression 
analyses (with short- and long-term attendance and substance use as criterion variables), 
above and beyond negative symptoms, depressive symptoms, and substance use severity 
(as indexed by the ASI Lifetime Substance Use). Negative symptoms, depressive 
symptoms, and substance use severity were entered into the first step and Reasons and 
Ability language strength were entered into the second step. 
Short-term treatment attendance. The full model was not significant [F(5, 20) 
= 1.58, R
2
 = .28, p = .21]. As revealed by the regression coefficients significance tests, 
none of the change language categories uniquely predicted treatment attendance; 
however, Ability strength (β = .41, t(19) = 1.93, sr
2
 =.13 , p = .07) approached 
significance. This finding should be interpreted in the within the context of the sample 
size it was conducted (n = 25); Ability language strength, given a larger sample size, may 
have emerged as significant whereby increased strength of statements during the 
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Motivational Interviewing session related to the client’s perceived self-efficacy to 
reduce/stop substance use would predict treatment attendance during the subsequent two 
weeks. 
Short-term substance use. The full model was not significant [F(5, 20) = 2.15, 
R
2
 = .35,  p = .10]. As revealed by the regression coefficients significance tests Ability 
language strength uniquely predicted short-term substance use during the subsequent two 
weeks of treatment (β = .43, t(19) = 2.11, sr
2
 =.15 , p < .05). These findings indicate that 
increased strength of statements during the Motivational Interviewing session related to 
the client’s perceived self-efficacy to reduce/stop substance use predicted substance use 
during the subsequent two weeks of treatment above and beyond depressive symptoms, 
negative symptoms, and substance use severity.  
Long-term treatment attendance. The full model was significant [F(5, 20) = 
1.49, R
2
 = .27, p = .24]. An examination of regression coefficients revealed that neither 
Reasons (β = .38, t(19) = 1.80, sr
2
 = .12, p < .09) nor Ability (β = .09, t(19) = .43, sr
2
 
=.01 , p = .67) language strength significantly uniquely predicted long-term treatment 
attendance. Of note, Reasons language strength did approach significance; given a larger 
sample size, Reasons language strength may have emerged as significant whereby 
increased strength of statements during the Motivational Interviewing session related to 
reasons for reducing/stopping substance use would predict treatment attendance during 
the duration of treatment. 
Long-term substance use. The full model was not significant [F(5, 20) = 2.40, 
R
2
 = .38,  p = .07]. Also, none of the predictors emerged as unique significant predictors 
(all ps > .05); however, Reasons language strength approached significance in predicting 
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the total number of clean urine samples obtained after the Motivational Interviewing 
session (β = .40, t(19) = 2.06, sr
2







Chapter 4: Discussion 
 The current study was the first of its kind to examine whether motivational 
change language, an important factor in predicting treatment outcomes, could be reliably 
characterized in individuals with serious mental illness, and the extent to which change 
language is associated with self-reported measures of motivation. Given the potential 
impact of symptomatology on therapy dynamics and processes, we examined whether 
negative symptoms are associated with change language and therapist behavior during 
Motivational Interviewing sessions. We also investigated the utility of change language 
in predicting substance use treatment outcomes. Finally, since clients’ negative symptoms 
could lead to increased therapist effort to facilitate client statements, we examined the 
potential role of therapist-prompted client language in Motivational Interviewing as an 
exploratory aim (see Appendix B). The following sections provide a detailed description 
of the findings, including limitations that were encountered and their implications in 
interpreting the current study’s results.  
Reliability of Change Language Ratings 
Overall, we found that change language frequency can be reliably rated across the 
language categories with sufficient data cells (Desire, Ability, Reasons, and 
Commitment), but that reliable strength ratings are difficult to ascertain in all of the 
change language categories except Ability and Reasons.  
Desire, Ability, Reasons, and Commitment language frequencies yielded 
“excellent” reliability according to Cicchetti’s (1994) guidelines; however, the reliability 
of strength ratings was extremely variable, ranging from “poor” to “good.” Low base 
rates of Need and Readiness language precluded the assessment reliability of frequency 
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and strength ratings for these language categories. There are numerous potential reasons 
for the lack of emergence of Need and Readiness language. It is possible that these 
particular language categories do not emerge frequently among individuals with serious 
mental illness receiving MI. Another possibility is that the particular structure of this 
Motivational Interviewing session did not lend itself to the client expressing the need and 
readiness to change substance use behavior, resulting in low frequencies of these 
language categories. Finally, raters may have had difficulty categorizing statements in 
these two categories. In many cases, there is ambiguity among types of change language 
statements. For instance, the statement, “I really need to stop using because I want to get 
my children back,” could have potentially been coded as a Need or Reasons statement. 
Similarly, “This time, I’m really ready to do what I need to do to stay clean,” may have 
been coded as a Readiness or Commitment statement. In turn, these difficulties in 
categorization of client statements may have lead to decreased frequency of Readiness 
and Need language.  
Prior studies suggest that Readiness and Need language are infrequently uttered or 
are difficult to code. Findings by Amrhein (2003) indicated that both Need and Readiness 
language exhibited the lowest frequencies (mean occurrences per session were .68 and 
.16, respectively), suggesting similar difficulties in categorizing these statements. A study 
by Baer (2008) did not code Need or Readiness language (but did code Desire, Ability, 
Reasons, and Commitment language). Though not explicitly stated, it is possible that the 
research group encountered low Need and Readiness language frequencies, and therefore 
did not include them in the analyses. 
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Although Ability and Reasons language strength evidenced good reliability, low 
base rates may have affected reliability of strength ratings for Desire and Commitment 
language. With respect to Desire language strength, an examination of the distribution of 
base rates revealed that there may not have been sufficient power to determine a reliable 
estimate of inter-rater agreement. Desire language only occurred twice or more in 13% (n 
= 6) of the sample. Whereas frequency ratings can be assessed for the full sample of 45, 
strength ratings can only occur for a subset of the sample (i.e., when the language 
actually occurred). Therefore, while low base rates have an impact on the reliability of 
frequency ratings, they have even greater impact on strength ratings, where the data 
available to calculate an ICC is significantly lessened. Also, the low sample size of the 
study most likely impacted our ability to yield reliable ratings, thereby compounding the 
issue of low base rates. 
Numerous studies reported using the MISC manual to code client language or 
reported coding numerous change language categories (Gaume, et al., 2008; Glynn, 2010; 
Magill, 2010; Moyers, 2006; Moyers, et al., 2007; Vader, et al., 2010). Such an approach 
would yield both frequency and strength ratings across all change language categories. 
Nevertheless, all of these studies dichotomized client language into change and counter-
change language categories and did not report findings on language strength. One study 
(Gaume, et al., 2008) explicitly indicated that low base rates led to the decision to use the 
dichotomous approach for change language frequencies, yet no findings were reported 
with respect to strength ratings. Another study (Baer, et al., 2008) reported findings 
incorporating reasons, commitment, and desire/ability, thereby combining categories. 
Instead of strength ratings, each category was dichotomized. This is peculiar in light of 
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frequent reference in these studies to Amrhein’s (2003) research, in which language 
frequency and strength were utilized in the analyses. This pattern of reporting suggests 
that base rates may have been an issue in prior studies. Moreover, Moyers et al. (2009), 
indicated that her research group has encountered repeated difficulty obtaining reliable 
strength ratings; however, potential reasons for this were not discussed. 
Despite these limitations, our findings support the idea that client change 
language can be reliably measured in this population when language frequency is 
considered, but that coding the strength of change language may prove difficult for 
coders.  
Aside from the observed issues with base rates in this study, there are numerous 
other possible reasons for the difficulty to reliably rate change language strength that are 
related to the coding procedures, namely the use of transcripts, the nature of the strength 
rating scale, coder training issues, and frequency of reliability assessment. Also, the study 
which achieved excellent change language strength reliability across all language 
categories (Amrhein, et al., 2003) utilized potentially problematic data analytic strategies 
which may have impacted the yielded reliabilities. Finally, sample characteristics may 
have contributed to difficulty coding language strength. Taken together, these issues 
potentially contributed to significant variability in change language strength scores in the 
current study, thus reducing reliability estimates. These issues are discussed below. 
One issue which may have affected strength rating reliability was the use of 
transcripts for coding rather than viewing live therapy sessions. Indeed, statements that 
are direct (e.g., “I am really gonna do it this time”) are easily judged as stronger than 
indirect statements (e.g., “There is no question about how important it is for me to stop 
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using”); however, the magnitude of the strength difference may be difficult to 
characterize on a 10-point scale without hearing the client’s statement. In this way, it is 
difficult to assess the language strength from transcripts, as there are numerous other 
aspects of language that could potentially be used to judge the strength of expressed 
attitudes (Searle, 1969) which cannot be captured in a transcript, such as voice 
inflections, prosody, facial expressions and gestures.  
Anecdotally, the raters reported having difficulty making strength ratings and 
indicated that it would have been easier to make strength ratings had the scale had a 
smaller range (e.g., -3 to +3 instead of -5 to +5). They also reported frequently using 
strength ratings of +3 and +4, thus artificially, although not intentionally, restricting the 
range of scores. Therefore, while it is easy to distinguish between change talk and 
counter-change talk, it is difficult to distinguish between a strength rating of, say, +2 or 
+3 when using transcripts. Amrhein, et al.(2003) used transcripts and reported an ICC of 
.83 for the mean strength across categories; however separate ICCs were not reported for 
each language category. Therefore, it is not clear whether poor strength ratings may have 
been encountered in some language categories and not in others. Other studies which 
used transcripts (Magill, 2010; Moyers, et al., 2006; Moyers, et al., 2007) did not report 
on strength ratings despite reporting having used coding procedures which incorporate 
language strength. Another study (Moyers, et al., 2009) utilized a combination of 
transcripts and audiotape and explicitly emphasized that their research group uses this 
approach consistently. Nevertheless, they reported having difficulty obtaining reliable 
strength ratings across numerous studies, suggesting that perhaps the use of audiotape 
does not present added benefit. 
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Another issue which may have affected the reliability of strength ratings is coder 
training. The transcripts that were not used in the current study (i.e., transcripts from a 
Motivational Interview that was conducted at a later point in the parent study) were used 
to train coders until an acceptable reliability level was maintained over six transcripts. 
Furthermore, a more stringent method of assessing coder reliability was used during the 
training period than for the study. Specifically, we used utterance-by-utterance agreement 
rather than the agreement between raters on the mean frequencies and strength of each (as 
was used in past studies). Nevertheless, the sample transcripts differed from the study 
transcripts in ways that may have affected reliability. For instance, the transcripts used 
were from a second Motivational Interviewing session conducted 3 months into the 
parent study. The nature of this Motivational Interviewing session differs in that the 
central focus is on maintaining abstinence achieved to that point or on problem-solving 
failed abstinence/reduction attempts, rather than on the broader topics of consequences of 
substance use, feedback, and goal setting, which were the focus of the current study’s 
Motivational Interviewing sessions. Therefore, the language may have been easier to 
code or there may have been less heterogeneity in emerging language, thus yielding 
better reliability. An alternative approach to the current study’s training approach might 
have been to create artificial transcripts which resembled the study’s transcripts in focus 
and scope.  
Another issue related to training was the frequency of rater meetings. In the 
current study, meetings were held bi-weekly to discuss general coding issues. 
Additionally, the author was available via email to address issues between meetings. In 
order to make sure that both coders had access to the same information, any responses to 
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questions were forwarded to both coders. Despite efforts to prevent rater drift, weekly 
meetings may have served to keep coders consistent.  
A final issue which may have affected inter-rater consistency was the fact that 
once the study transcripts were provided to raters for coding, no other efforts were made 
to assess consistency for the duration of the study. An alternative approach would have 
been to determine ICCs at various points during coding and address issues that arose. In 
the current study, such an approach was not used as it could potentially introduce 
variability in ratings across time because coders could potentially change their 
conceptualization of various aspects of the coding procedure.  
Finally, uncertainty regarding making strength ratings may have introduced 
significant variability to the data, thus reducing the observed agreement between raters. 
Again, prior studies which examined change language dichotomized ratings into change 
talk and counter-change-talk (Baer, et al., 2008; Gaume, et al., 2008; Gaume, et al., 2010; 
Glynn, et al., 2010; Magill, et al., 2010; Moyers, et al., 2003; Moyers, et al., 2007; 
Moyers, et al., 2009; Vader, et al., 2010), thus reducing the amount of potential variation 
and clarifying rating distinctions for raters. Again, this pattern of reporting also brings 
into question whether these studies may have originally attempted to use the full range of 
strength ratings, but did not indicate whether attempts to rate language strength were 
unsuccessful.  
Another factor that may have impacted the pattern of findings with respect to 
strength language across studies is Amrhein’s (2003) method of addressing missing cells 
for language strength ratings. Amrhein’s research group imputed data values for strength 
of categories using an expectation-maximization algorithm, but did not report the base 
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rates of change language. This approach is typically used in self-report measures where 
there is missing data and missing values can be inferred from the values present in the 
data set. The use of this data imputation method is problematic when considering ratings 
of client language strength, particularly if there were large amounts of missing values due 
to low base rates of change language frequencies. Essentially, imputed values would 
represent strength ratings for change language which did not occur. Moreover, it was not 
clear whether a base rate threshold was set in order to allow for imputation of data; 
therefore, the percentage of data that was imputed was not clear. In the current study, 
values for strength ratings were not imputed due to the aforementioned limitations of this 
approach, therefore, Amrhein’s (2003) data analytic approach may have explained why 
this study and others (see Moyers, 2009) failed to yield reliable strength ratings. It is 
possible that the ratings may not have been reliable if this artificial correction were not 
applied. 
A final factor which might have impacted strength reliability is sample 
characteristics which differed from Amrhein’s (2003) study.  It is possible that clinical, 
sociodemographic or substance use-related characteristics could have impacted the way 
that language unfolded over the course of the Motivational Interviewing session, making 
language more difficult to code. With respect to clinical characteristics, perhaps there are 
aspects of having serious mental illness which could interfere with the ability to garner 
strength ratings. The current study had a high percentage of individuals with bipolar 
disorder, which during mania, is characterized by flight of ideas. This could have made 
strength ratings more difficult. Furthermore, the high sample composition of individuals 
with schizophrenia spectrum disorders may have introduced such complicating factors as 
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loosening of associations and dissociation. Although the clinical composition of 
Amrhein’s sample was not specifically delineated, and likely did include individuals with 
psychiatric problems, the study was likely not comprised of individuals with serious 
mental illness.  
With respect to sociodemographic factors, the current study was similar to the 
prior study in that the sample was a low income inner-city sample with average education 
of about 12 years. Where the two studies diverge is in the ethnic composition (Amrhein’s 
study was more diverse) and in the distribution of individuals who abuse various drugs 
(cocaine, crack, heroin, and “other”). The current study is composed primarily of crack-
cocaine users. While the nature of the impact of these differences cannot be theoretically 
derived, it is possible that these differences introduced variance which may have 
impacted strength ratings.  
Relationships among Change Language Categories and to Self-Report Measures of 
Motivation 
 In order to establish evidence of validity of change language ratings, we 
examined, (1) whether the interrelationships of change language dimensions reflected 
that of prior studies and, (2) whether the pattern of convergence of change language 
categories on self-reported measures of motivation to change occurred as would be 
expected according to their face validity. Overall, there was little evidence of 
concordance between change language and self-reported measures of motivation, except 
in the case of the Ability language strength, which demonstrated significant, high 




We examined whether the structure of relationships among change language 
categories reflected that of a prior study (Amrhein et al., 2003) in which Desire, Ability, 
Reasons, and Need language strength each accounted for unique variation in 
Commitment language. According to these findings and research by other groups (Hall, 
Havassy, & Wasserman, 1990; Marlatt, Curry, & Gordon, 1988; McKay, Alterman, 
Cacciola, O’Brien, Koppenhaver, & Shepard, 1999; Mussell, Mitchell, Crosby, 
Fulkerson, Hoberman, & Romano, 2000), increasing the client’s will (desire), perceived 
ability (self-efficacy), need, and reasons to change should result in increases in 
commitment to change. Although the frequency of statements related to a client’s will to 
change substance use behavior was not uniquely related to commitment language in this 
study, clients’ statements of perceived ability and reasons for change were uniquely 
related to commitment language frequency, accounting for 40% and 10% of unique 
variance (respectively) in the frequency of commitment statements. These findings 
suggest that the generation of statements regarding self-efficacy and reasons to 
reduce/stop substance use are unique indicators of the client’s stated commitment to 
change. The fact that Desire statements did not account for a significant amount of 
variance in Commitment strength may be due to the overlap of shared variance between 
Desire and Ability. Therefore, these results are largely consistent with Amrhein et al. 
(2003), in which Commitment statements were found to be comprised of the underlying 
dimensions of Desire, Ability, and Reasons.  
 We found little evidence of agreement between change language categories and 
self-reported measures of motivation to change. With respect to language frequencies, 
there were no relationships between change language and self-reported assessments of 
86 
 
general readiness to change, drug and alcohol abstinence self-efficacy, decisional 
balance, or processes of change. There was, however, evidence of a preferential 
relationship of increased Ability language strength with increased self-reported drug and 
alcohol abstinence self-efficacy. Indeed, the magnitude of the association of Ability 
language strength to self-efficacy was not significantly greater than that to self-reported 
decisional balance (pros); however, due to the lack of power, it is reasonable to suggest 
that given a sufficient sample size, that this difference may have been significant. The 
fact that Ability language strength is related at such a high magnitude to self-efficacy 
measures suggests that Ability language is indeed tapping an aspect of motivation 
specifically associated with clients’ self-efficacy to reduce/stop drug use in this sample.  
One possible explanation for the lack of agreement between self-report measures 
of motivation and change language is the fact that self-report measures are completed one 
to two weeks before the Motivational Interviewing session. It is possible that motivation 
may change during this time frame. Another possibility is that the method of assessment 
(self-report versus interview by a therapist) played a role in obtaining differing appraisals 
of motivation. Nevertheless, this is the first study to examine concordance between self-
report measures of motivation and change language; therefore, further research is needed 
to make firmer conclusions in this area. 
Relationships among Change Language, Therapist Behavior, and Negative 
Symptoms  
 We sought to examine the potential relationship between negative symptoms and 
the emergence of change language during MI. Of note is that there was a restriction of 
range of negative symptoms in this sample. Specifically, the mean number of negative 
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symptoms was low for most participants. This may be attributable to the measurement 
instrument or to the diagnostic composition of the sample. In the current study, we used 
the PANSS to assess negative symptoms, which presents numerous limitations in validly 
measuring negative symptoms (see Blanchard, Kring, Horan, & Gur, 2011), including 
content validity. Therefore, it is possible that negative symptoms which were truly 
present in the current sample were not detected by the measurement instrument. 
 Another possibility is that there was truly a lack of negative symptoms  in the 
sample. Schizophrenia, which is partially characterized by the presence of negative 
symptoms, was only present in one participant. Both schizoaffective disorder and 
psychosis, which accounted for 26.7% of the sample, are associated with significantly 
fewer negative symptoms than in schizophrenia (Bora, Yucel, & Pantelis, 2009). 
Furthermore, bipolar disorder, which constituted most of the sample (51.1%), is also 
associated with the presence of significantly fewer negative symptoms than schizophrenia 
(Barrett, Mulholland, Cooper, and Rushe, 2009). Furthermore, the mean negative 
symptoms in the current study were significantly lower (1.7 standard deviations) than in a 
large multi-center study of individuals with schizophrenia (Clinical Antipsychotic Trials 
of Intervention Effectiveness (CATIE), 2005).  This suggests that negative symptoms 
were severely limited in this study, thus possibly contributed to the restriction of range 
and the resulting inability to detect relationships between negative symptoms and change 
language. Therefore, the current findings must be interpreted within this context. The 
current sample does not reflect a true sample of individuals with a range of negative 
symptoms. If this were not the case, there might have been a relationship between 
negative symptoms and change language. 
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In understanding the relationship between negative symptoms and Ability 
language, the context in which Ability statements were made must be understood. Most 
Ability statements were made during the portion of the Motivational Interviewing session 
when a plan for change and potential obstacles (e.g., risky situations and triggers) were 
discussed. Therefore, one possible explanation for the association between negative 
symptoms and Ability language is that those with increased negative symptoms 
expressed less confidence in their ability to either plan for change or navigate risky 
situations surrounding substance use. This would be consistent with research which has 
found robust associations between increased negative symptoms and decreased social and 
cognitive functioning (e.g., Blanchard, Horan, & Collins, 2005; Bozikas, Kosmidis, 
Kioperlidou, & Karavatos, 2004), which in turn are critical to effectively evaluate various 
options to achieve change, engender the necessary social support system for recovery, as 
well as engage in the complex set of behaviors necessary to resist substance use and 
make and maintain change.  
 There was no evidence of an association between increased negative symptoms 
and decreased frequency of any language category or Reasons language strength. 
Moreover, there was no relationship between negative symptoms and therapists’ use of 
MI-consistent behavior. These findings may have been due to the aforementioned 
restriction of range issues. Another possible explanation is the link between MI-
consistent therapist behavior and frequency of client language. Therapists’ use of 
Motivational Interviewing skills were associated with client statements related to reasons 
for reducing/stopping substance use and marginally linked to expressed desire and 
commitment to reduce/stop. Indeed, in prior research, the emergence of change language 
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has been found to be contingent upon the therapists’ use of MI-consistent skills (Gaume, 
Bertholet, Faouzi, Gmel, & Daeppen, 2010; Moyers, Moyers, Martin, Houck, 
Christopher, & Tonigan, 2009; Vader, Walters, Prabhu, Houck, & Field, 2010). In this 
way, it was thought that perhaps therapists execute more MI-consistent skills when a 
client does not seem to be engaging, such as might be the case in individuals with 
increased negative symptoms; however, the current study found no relationship between 
MI-consistent therapist behaviors and negative symptoms or the specific symptoms of 
alogia. Again, this finding has limited interpretability given the lack of range of negative 
symptoms in this sample.  
The current study found evidence of the impact of therapists’ use of MI-consistent 
skills on the emergence of client change language. Sequential analysis approaches to 
examining therapists’ use of Motivational Interviewing skills and change language have 
found that MI-consistent behaviors precede the emergence of change language (Gaume, 
Bertholet, Faouzi, Gmel, & Daeppen, 2010; Moyers, Moyers, Martin, Houck, 
Christopher, & Tonigan, 2009; Vader, Walters, Prabhu, Houck, & Field, 2010). In the 
current study, there was evidence that therapists’ increased use of MI-consistent 
behaviors was associated with increased frequency of statements related to reasons for 
reducing/stopping substance use. Taken together with past findings, this suggests that 
therapists can indeed elicit change language in clients with serious mental illness by 
practicing Motivational Interviewing therapist skills. Nevertheless, therapists' increased 
use of MI-consistent behaviors was not associated with either substance use treatment 
outcomes or Ability language, which did in fact predict outcome. This finding is 
inconsistent with the idea that hypothesized mechanism by which MI affects treatment 
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outcome is through the therepist's elicitation of change language, which in turn is an 
indicator of favorable outcomes. Indeed, this study's use of correlational rather than 
contingency analyses limits the ability to draw firm conclusions regarding mechanisms 
underlying MI as they relate to therapist behaviors and their relations to change language 
and outcome.  
Although the current study elucidated some univariate associations among change 
language, therapist behavior, and negative symptoms, more work is needed to better 
characterize these associations and capture the interactional nature of therapist 
Motivational Interviewing skills, client behavior, and symptomatology. 
Change Language as a Predictor of Substance Use Treatment Outcomes 
Given the size of the effects for those relationships which did not quite reach 
significance and the low achieved power of this study (approximately 40% and 27% for 
frequency and strength ratings, respectively), we discuss here statistically significant as 
well as marginal effects, as we feel that given adequate power, these marginal effects 
might have been significant.  
The number of client statements regarding self-efficacy in changing substance use 
behavior emerged as a prospective predictor of attendance at the 6-month behavioral 
treatment program which followed the Motivational Interviewing session. Specifically, 
increased frequency of Ability language predicted better long-term treatment 
engagement, accounting for 11% of the variance. Ability frequency also marginally 
predicted long-term substance use (7% of the variance). 
Despite reduced availability of data for strength analyses, the strength with which 
clients made Ability statements predicted substance use two-weeks after the Motivational 
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Interviewing session (and marginally predicted short-term attendance). Increased strength 
of Ability language predicted less short-term (two weeks after the Motivational 
Interviewing session) substance use (15% of the variance) and marginally predicted 
better short-term attendance (13% of the variance). Finally, greater strength of statements 
related to Reasons language marginally predicted better long-term treatment engagement 
(12%) and less substance use (13%).  Of note is that the incremental validity of these 
language predictors in predicting substance use treatment outcomes was above and 
beyond other known predictors in prior research (i.e., depressive symptoms, negative 
symptoms, and substance use severity). However, a major limitation of the finding with 
respect to substance use outcome is that the index of substance use in the current study is 
confounded by treatment engagement. Specifically, the total number of clean urine 
samples provided was contingent upon participants’ treatment attendance.   
In contrast to studies which found that Commitment language strength was the 
target language component in determining treatment outcomes (Aharonovich, et al., 
2009; Amrhein et al., 2003), the current study revealed the importance of Ability 
language frequency in this sample. Also, despite a significant association between Ability 
and Commitment language statements, the current study found ability statements to be 
predictive of outcome, while the aforementioned studies found support for commitment 
language to be an indicator of outcome. Therefore, the relevance of commitment 
language to substance use outcomes in the current study is not clear. However, these 
findings are consistent with a study (Mann-Wrobel, Bennett, Weiner, Buchanan, & Ball, 
in press) which found self-efficacy to quit smoking to be more central to cessation efforts 
than readiness for change alone. 
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The Relationship of Self-Reported Motivation to Change to Substance Use 
Treatment Outcomes 
 Consistent with previous findings in the larger parent study sample which found 
that the C-SOC was associated with increased treatment utilization and decreased 
substance use, (Strong-Kinnaman, Bellack, Brown, & Yang, 2007), readiness for change, 
as measured by the C-SOC, emerged as a significant predictor of increased short-term 
treatment attendance and decreased substance use. Nevertheless, other self-report 
measures of motivation did not significantly predict outcome. This may speak to the 
utility of the C-SOC in assessing motivation for change in serious mental illness over 
other measures. The C-SOC was not related to long-term outcomes. This is not surprising 
given the timing of the assessment  in relation to the measurement of the outcome (i.e., 
self-report measures were administered once at the beginning of the study). Given that 
motivation to change is thought to wax and wane over time, it is possible that one 
assessment of motivation that is not sufficient to predict longer-term outcomes.  
The Relationship of MI-Consistent Therapist Behaviors to Substance Use 
Treatment Outcomes 
 In contrast to a study which found an effect of Motivational Interviewing skills on 
alcohol use outcome (Moyers et al., 2009), the current study found no such link. 
Therefore, taken together with the findings that Ability statements were predictive of 
outcomes, but that MICO therapist behaviors were not linked to Ability statements, the 
proposed causal chain for Motivational Interviewing is not supported in this study. One 
possible reason for this may be that  there were numerous confounds between the time of 
the Motivational Interview and the measurement of outcomes, the most likely of which 
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was a behavioral treatment for substance use. It may be the case that in a more controlled 
study, the impact of MICO therapist behaviors on outcome would have emerged. 
The Context of Client Change Language Statements and Implications for Substance 
Use Treatment  
The context in which these statements happen are important in better 
understanding the relevance of Ability language to substance use treatment outcomes in 
this sample. A close examination of the data revealed that most of the Ability language 
generated in this sample was during the part of the session when clients discussed risky 
situations and triggers and that most of these statements were of negative strength. This 
means that most clients who generated Ability language identified situations in which 
they found it difficult to resist using drugs. This, in turn, was predictive of long-term 
engagement and short-term substance use (and possibly long-term substance use).  
Perhaps it is the case that the more risky situations/triggers the client identifies 
(hence more Ability statement generation), the more they are able to practice handling 
those situations, which would result in less substance use throughout treatment. Also, 
perhaps it is the case that because clients are aware that they have numerous difficulties 
resisting drug use, they are more likely to attend treatment sessions and find them useful, 
thus accounting for the predictive utility of Ability language for treatment attendance. 
This study’s findings regarding the predictive utility of Ability language in both 
treatment engagement and substance use outcomes speak to the importance of discussing 
risky situations and triggers for substance use during Motivational Interviewing sessions 
for individuals with serious mental illness; however, it is not clear at this point whether it 
is the mere discussion and/or the client’s awareness of risky situations and triggers which 
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is the underlying mechanism. Indeed, discussing situations in which clients find it 
difficult to resist substances would generate increased Ability language. This discussion 
would then allow for the subsequent dialog about how to handle these situations. This 
would particularly be the case given the nature of the Motivational Interviewing sessions 
in the current study. As part of this manualized treatment, therapist were trained to 
discuss risky situations and then to help the client generate ideas on how the client would 
handle these situations. Furthermore, during the behavioral treatment which followed the 
Motivational Interviewing session, specific drug refusal skills were practiced that were 
tailored to clients’ specific triggers and identified risky situations.  
While Ability language frequency may represent the number of situations a client 
can identify as risky situations, Ability language strength may represent the extent to 
which clients express self-efficacy in handling risky situations. For each Ability 
statement, the rater provided a strength rating, which may be interpreted as the 
confidence (or lack thereof) with which the client said that they could or could not handle 
a risky situation/trigger. For example, “I may be able to deal with my brother if he offers 
me marijuana,” would be rated lower than, “I would definitely be able to say no to my 
brother if he offers me marijuana.” Along these lines, those with more confidence 
evidenced less short-term, but not long-term substance use; therefore, perhaps confidence 
in and of itself is not sufficient in maintaining long-term abstinence, but may be enough 
for the client to abstain for two weeks. It is also possible that confidence is not stable over 





Other Predictors of Substance Use Treatment Outcome 
A final point regarding the prediction of treatment outcomes is that within this 
sample, depressive symptoms and substance use severity predicted favorable treatment 
outcomes. That is, contrary to prior findings which demonstrate a consistent relation of 
poor treatment outcomes to greater substance use severity (e.g., Ahmadi, Kampman, 
Oslin, Pettinati, Dackis, & Sparkman, 2009; Hanlon, O’Grady, & Bateman, 2000) and 
higher levels of depressive symptoms (Brewer, Catalano, Haggerty, Gainey, & Fleming, 
1998; Carroll, Power, Bryant, & Rounsaville, 1993), higher depressive symptoms and 
higher substance use severity predicted better long-term treatment attendance. Also, 
higher depressive symptoms significantly predicted less long-term substance use. Despite 
this, depressive symptoms and self-reported levels of distress have been associated with 
positive treatment outcomes among substance abusers (Dackis & Gold, 1987; Kosten & 
O’Connor, 2003), suggesting the role of subjective distress in treatment-seeking and 
retention. Also, baseline depressive symptoms may be secondary to substance use and 
withdrawal symptoms, and have been found to decline throughout treatment (Glasner-
Edwards, Marinelli-Casey, Hillhouse, Ang, Mooney, & Rawson, 2009) thereby 
potentially reducing the negative effects of symptoms on outcome as treatment 
progresses. However, given the current sample of individuals with serious mental illness, 
depressive symptoms are more likely to be explained by pre-morbid psychopathology 
rather than symptoms secondary to substance use or withdrawal symptoms. In the current 
study, post-treatment depressive symptoms were not considered, thereby limiting our 
ability to assess the stability of depressive symptoms throughout treatment and its 
interaction with treatment outcomes. However, the behavioral treatment which followed 
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the Motivational Interviewing session (BTSAS; Bellack et al., 2006) addressed dual 
diagnosis issues; therefore, it is possible that symptoms either decreased during treatment 
or the impact of symptoms on substance use issues decreased throughout treatment. Also, 
because there were specific treatment modules focused on depression and coping with 
substance use problems, those with increased depressive symptoms (and perhaps 
increased awareness of their symptoms) may have experienced additional benefit from 
the treatment, thereby improving treatment outcome for these individuals. Many 
individuals were also seeking concurrent psychiatric care, a factor which has been 
associated with substance use treatment success (see Appendix A for a brief review of 
integrated treatment for individuals with serious mental illness). Perhaps those with more 
severe symptoms were among those who were more likely to seek such care and 
therefore experienced more favorable treatment outcomes. 
The finding with respect to substance use severity predicting treatment attendance 
may be attributable to the way that this variable was operationalized. Past studies have 
utilized a composite derived from the Addiction Severity Index to characterize severity, 
which includes the areas of substance use, medical, legal, family, vocational, and 
psychiatric problems. The ASI has been found to be reliable and valid among individuals 
with a concurrent psychiatric disorder (Hodgins & El-Guebaly, 1992); however, the 
reliability of the domains of legal, family, and employment were unfavorable. 
Furthermore, some specific questions were not useful in characterizing substance use 
among individuals with serious mental illness (Course, Herschinger, & Zanis, 1995) Due 
to these issues the composite score was not used, but rather the single self-report item of 
years of past substance use. This method could have been limited in its ability to capture 
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the full scope of the construct of substance use severity and thus not replicating the 
previous findings regarding the prediction of treatment outcomes. Another possibility is 
that among individuals with serious mental illness, substance use severity serves as a 
protective factor in motivating individuals to attend treatment consistently once contact 
with a treatment center is made. 
Limitations and Future Directions 
 Despite the informative findings regarding motivational statements during 
treatment for substance use among individuals with serious mental illness, there are 
numerous limitations which must be addressed. Specifically, issues related to (1) sample 
size, (2) clinical characteristics, (3) potential confounding factors, (4) the Motivational 
Interviewing session structure, (5) coding methods, (6) methods of determining substance 
use treatment success, and  (7) not exploring the contingency between therapist behavior 
and client change language may have limited our ability to garner firmer interpretations 
of the data. 
 The small sample size greatly limited many aspects of the study. The power to 
detect effects, particularly for change language strength data, was extremely low.  
Therefore, is not clear whether the low occurrence Need and Readiness language 
reflected difficulty in identifying and coding these categories, lower likelihood of 
occurrence in this sample compared to other samples, or just a consequence of the low 
sample size. Furthermore, because ICCs are affected by sample size, it is not clear 
whether the inadequate reliability ratings yielded for change language strength was truly 
due to difficulty making strength ratings, or whether given an adequate sample size, these 
ratings might have reached an acceptable level.  Low power due to small sample size may 
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have limited the ability to detect relationships between change language and self-report 
measures of motivation. Also, this problem likely impacted our ability to detect 
preferential correlations between change language categories and self-report measures of 
motivation, and also to detect effects of predictors of substance use treatment outcome. 
Future studies should ensure adequate sample size so that the aforementioned issues may 
be avoided. 
 Clinical characteristics of the current study also presented a limitation. Negative 
symptoms are a feature of schizophrenia spectrum disorders, primarily among individuals 
with schizophrenia, who comprised only 2.2% of the sample. Therefore, a limited amount 
of the sample exhibited elevated levels of negative symptoms. This in turn hindered our 
ability to reliably test hypotheses regarding the relationship among negative symptoms, 
client language, and therapist behavior. The sample was comprised primarily of 
individuals with bipolar disorder, which presents with its own unique set of 
characteristics which could hinder motivation and attempts to change substance use 
behavior. The sample was not large enough to conduct analyses to investigate potential 
differences in change language according to diagnostic category. Future studies should 
include more individuals with schizophrenia in order to be able to evaluate the impact of 
negative symptoms on motivation to change substance use behaviors. Furthermore, in 
order to expand the generalizability of future studies, a sample which includes adequate 
sample sizes of individuals with various diagnoses should be included. 
 The current findings cannot be generalized to all individuals receiving 
Motivational Interviewing for substance use due to other components of the treatment 
which may influence outcome. Specifically, after the Motivational Interviewing session, 
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participants attend a behavioral treatment for substance use twice a week for six months. 
This treatment includes a contingency management component. Therefore, external 
motivators may act as a confound on substance use treatment outcomes in the current 
study, thereby limiting generalizability.  
 Tailoring Motivational Interviewing therapy sessions to individuals with serious 
mental illness required the imposition of increased structure upon the Motivational 
Interviewing session in order to better accommodate individuals with cognitive 
difficulties. This, in turn, may have changed the patterns and frequencies of language 
which manifest compared to other studies. For instance, during the feedback portion of 
the session, some of the client’s answers to self-report items are reviewed and the client is 
reinforced for the steps they have taken to change substance use behavior. This is in 
contrast to the more common Motivational Interviewing approach of providing 
comparative feedback to the client regarding the amount of substance use he/she is 
engaged in and having a discussion about it. In the current study, the feedback section 
generated very little change language across all language categories compared to the 
other two sections. One could potentially see how a discussion about the client’s 
substance use might generate not only more change language, but also more counter-
change language.  
The imposed structure on the Motivational Interviewing session is in contrast to 
the more free-flowing nature of Motivational Interviewing sessions that are not tailored 
for those with serious mental illness. This may have impacted the emergence of change 
language in that the therapist more strictly determines the nature of the conversation by 
having a set of specific goals for the session (i.e., discussing consequences of substance 
100 
 
use, providing reinforcing feedback, discussing triggers/risky situations, and goal 
setting). Therefore, for instance, discussing hypothetical situations that could potentially 
hinder abstinence makes it almost certain that Ability statements will occur, whereas this 
is not necessarily so during a less structured session. Nevertheless, the structured nature 
of these sessions may contribute to increasing the signal to noise ratio by reducing the 
variance in overall language (noise) and thus allow for more refined detection of 
differences in the frequencies and strengths of these language categories (signal). 
Another effect that the structure of the Motivational Interviewing session could 
have had on the emergence of change language is that the disadvantages of changing 
substance use behavior were not explored. Such discussion typically occurs during a part 
of the session when the therapist guides the client in decisional balance exercises (i.e., 
weighing the pros and cons of changing and not changing). Only the pros of change and 
the cons of not changing were explored during the part of the session when consequences 
of use were discussed. This generated Reasons change language, but not Reasons 
counter-change language. This may have impacted findings regarding the association 
between Reasons language and self-report decisional balance measures by limiting the 
scope of discussion surrounding decisional balance and also by limiting the range of the 
Decisional Balance scales. Therefore, taken together with the aforementioned issues 
related to the structure of the current study’s Motivational Interviewing session, it can be 
concluded that it is difficult to compare the findings of the current study to other studies 
examining change language. More studies using the current protocol are needed to 
confirm the salience of specific change language categories during Motivational 
Interviewing sessions for individuals with serious mental illness. 
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 Another characteristic of the Motivational Interviewing session protocol which 
posed a limitation was that not all clients engaged in a discussion with the therapist about 
triggers/risky situations and goal setting. Ability statements were most frequently 
exhibited during this time. Sometimes this part of the session was done during the 
behavioral group which followed the Motivational Interviewing session. Therefore, only 
a subset of clients engaged in the portion of therapy which garnered the most Ability 
statements. Future studies should employ a standardized protocol for Motivational 
Interviewing sessions in order to ensure that all change language categories have equal 
probability of emerging for every client. Due to sample size restrictions, it was not 
possible to do analyses separately for those who received this part of the session and 
those who did not.  
 The coding method of using transcripts greatly limited the coders’ ability to make 
strength ratings. Language structure is one of many dimensions which could be used to 
make a reliable strength rating (e.g., inflections, prosody, facial expressions, body 
language). Therefore, future studies should use video to provide language ratings so that 
more information is available to coders to provide ratings. 
 In the current study, substance use “success” was defined by a clean urine 
toxicology screen, which detects any substance use in the past three days. Therefore, we 
were not able to measure success for those clients whose goal was to cut down on 
substance use.  High concordance has been found between self-reports of substance use 
and urine analysis (Zanis, 1994); therefore future studies should consider using a 
combination of self-report and urine screens so that harm reduction goals may be 
considered in addition to abstinence goals.  
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 Prior studies of therapeutic processes underlying Motivational Interviewing have 
suggested that it is the resolving of ambivalence that is the operative mechanism 
underlying treatment success. In terms of client language, ambivalence manifests as 
change language “sandwiched” in between counter-change language (Moyers, 2009). The 
current study did not use sequential analysis to get a better sense of the longitudinal 
pattern of change language in order to investigate this idea. Future studies should 
consider using sequential analysis methods in order to understand the unfolding of 
change language patterns among individuals with serious mental illness. 
 Despite these limitations, the current study has provided a preliminary 
characterization of change language in a sample of individuals with serious mental 
illness. As such, reliable ratings were yielded for Desire, Ability, Reasons, and 
Commitment language frequency and for the strength of Ability and Reasons language. 
Ability language emerged as a significant factor in predicting substance use treatment 
outcomes, which suggests that client statements regarding self-efficacy to reduce or stop 
substance use are particularly important among individuals with serious mental illness. 
Future studies should seek to determine why Ability language is salient. Specifically 
whether it is the client’s insight into their triggers/risky situations that is the key 
mechanism, or whether it is the subsequent ability to navigate these situations which 
accounts for favorable outcomes. Also, an investigation of the relationship among 
symptomatology, client change language, and therapist behavior is warranted in order to 
better understand motivation among individuals with serious mental illness. 
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Appendix A: Treatments for Dual Diagnosis 
 The traditional method of treating dually diagnosed patients was in a sequential 
manner, whereby patients are treated for psychiatric problems on an inpatient basis and 
then through outpatient mental health treatment combined with 12-Step meetings 
(Alcoholics Anonymous [AA] and/or Narcotics Anonymous [NA]). In the parallel 
approach to treatment, both substance abuse and psychiatric problems are treated at the 
same time, albeit by different providers. In individuals with SMI, both of these 
approaches fall short of being effective (Judd, Thomas, Schwartz, Outcalt, & Hough, 
2003; Fletcher, Cunningham, Calsyn, Morse, & Klinkenberg, 2008). A complicating 
factor which prevents the combination of psychiatric and substance abuse treatment is the 
fact that these programs have different foci (Tsuang & Fong, 2004). Mental health 
programs emphasize symptom reduction, the importance of empathy, the use of 
pharmacotherapy, and crisis management. In contrast, substance use treatment is often 
based on the attendance of 12-step groups, where the prevailing philosophy is based in 
“tough love” and is often not supportive of the use of pharmacotherapy. 
A more seamless and effective approach to dual diagnosis treatment, integrated 
care (Mueser & Drake, 2007), addresses both disorders using a multidisciplinary 
treatment staff. Integrated treatment often involves various types of mental health 
professionals, is designed to address the complex needs of dually diagnosed clients, and 
often includes the modification of interventions to incorporate components to address 
substance use, mental illness, and their interaction (Drake, Essock, & Shaner, 2001).  
Individuals with schizophrenia present with negative symptoms and cognitive 
deficits, which can interfere with substance use treatment engagement. Within the context 
104 
 
of the traditional substance abuse treatment model, negative symptoms such as 
amotivation and avolition may be interpreted by providers as denial or something that the 
patient actually has control of when this is not the case. As a result, there can be 
increased instances of confrontation with treatment staff (Tsuang & Fong, 2004). Further, 
cognitive deficits such as diminished attention, and poor verbal fluency can make 
engagement in treatment difficult. In integrated treatment, such considerations necessitate 
the protraction of substance use therapy to accommodate these factors. Also, treatments 
may be altered to encourage much needed additional social support or to address 
medication compliance issues.  
Integrated treatment for individuals with depression and anxiety often involves 
cognitive, behavioral and cognitive-behavioral approaches. These may include helping 
the client to understand comorbidity, teaching coping strategies, incorporating behavioral 
activation strategies (Daughters, Braun, Sargeant, Reynolds, Hopko, & Blanco, et al., 
2008), thereby seeking to reduce both psychiatric symptoms and substance use (Hesse, 
2009). In many cases, pharmacotherapy is incorporated. 
Ultimately, the main goal of the integrated approach is to help patients manage 
both illnesses such that they may attain their life goals. Patients’ unique contexts are 
considered in the provision of services. Emerging from this integrated approach was the 
need for motivational interventions that could address the needs of dually diagnosed 
clients who either were not ready to seek treatment for their substance use or did not 
recognize either their substance use or mental illness as needing to be addressed.  
Numerous empirically supported psychosocial treatments exist for dual diagnosis. 
The most commonly used and effective treatments include case management / assertive 
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community treatment, cognitive behavioral therapy (CBT), relapse prevention (which is 
based on CBT principles), 12-Step programs and facilitation, social skills training, and 
contingency management. To address the client’s needs with respect to their family 
relationships, family training and education is often implemented as well. As a 
complement to these treatments, and consistent with an integrative model of dual 
diagnosis treatment, motivational approaches are often used and are effective  in 
addressing issues related to lack of engagement in treatment among individuals with 
severe mental illness (Drake, et al., 2004).  
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Appendix B: Therapist-prompted and Unprompted language 
 As an exploratory aim, we proposed to analyze all data including change language 
that was prompted by the therapist. For instance, the therapist might say, “Would you say 
that your family is one reason that you want to stop using drugs?” In this case, the client 
may respond, “Yes, my family is a reason to stop.” This is in contrast to the therapist 
asking, “What is one reason that you want to stop using drugs?” and the client 
responding, “I would say one big reason is because of my family.” It is not yet clear at 
this time whether it is the verbal declaration present in change language which is the 
active ingredient, or whether it is the case that change language is an indicator of some 
underlying processes that are driving motivation to reduce/stop substance use. If it is 
indeed the act of declaring commitment to changing substance use behavior that is the 
key component, then including therapist-prompted language should yield comparable 
results to when only completely spontaneous client language (unprompted) is analyzed. 
Descriptive data and summaries of these findings in comparison to considering only 
unprompted language statements are provided below. 
Base Rates of Language Occurrence. Paired samples t-tests indicated that the 
mean frequency of Desire, Ability, Reasons, Readiness, and Commitment language 
increased significantly when also considering acquiescent language (all ps < .05). 
Nevertheless, the base rates of Readiness and Need language were still too low to provide 
adequate power for analyses. 
Coder reliability. Similar ICCs were obtained for frequency across language 
categories (Desire, Ability, Reasons, and Commitment; .82-.95). For strength ratings, 
Reasons language yielded acceptable reliability (.77), but Ability language strength 
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decreased from .66 to .39, suggesting that when considering therapist-prompted language, 
the strength of client statements referring to their perceived ability to reduce/stop 
substance use are more difficult for coders to rate reliably. The strength of client 
statements related to reasons for changing substance use behavior maintained adequate 
reliability when considering prompted language.  
Inter-relationships among language categories. Zero-order intercorrelations 
among language categories when considering therapist-prompted language were similar 
to those yielded for unprompted language. Also identical to findings using unprompted 
language, Reasons and Ability language frequency (but not Desire) accounted for unique 
variance in Commitment language frequency.  
Relationship between change language and self-reported measures of 
motivation. There were few notable differences in patterns of relationships between 
change language and self-reported measures of motivation when considering therapist-
prompted language. One exception was the relationship between Reasons language 
strength and URICA Total (r = .36, p < .05) and Contemplation (r = .50, p < .01) scores, 
which became significant when considering prompted language. Additionally, the 
correlation of Reasons language strength with processes of changes subscales C-SOC 
Action (r = .36, p < .05) and Maintenance (r = .36, p < .01) scores became significant. 
These findings suggest that when considering reasons clients give for stopping/reducing 
substance use that are prompted by the therapist, the strength with which those reasons 
are given are positively related to self-reported measures of readiness for change, 
contemplation, action, and maintenance. Despite these slight differences in patterns of 
correlations, there was no evidence of preferential correlations between the strength of 
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change language and self-reported measures of motivation that were consistent with our 
hypotheses. 
Negative symptoms and client language. There were a couple notable 
differences in findings with respect to negative symptoms and change language. When 
considering acquiescent client language, negative symptoms were not related to the 
frequency of any change language category (all ps > .05); however, the previously 
evidenced relationship with Ability strength became non-significant and the relationship 
with Desire (r = -.53, p < .01) and Reasons (r = -.42, p < .01) became significant. When 
considering both therapist-prompted and unprompted change language statements, more 
negative symptoms were associated with a lower strength of statements related to desire 
and reasons to reduce/stop substance use; however, when considering only statements 
that are not prompted by the therapist, only the strength of statements related to the 
client’s perceived ability to reduce/stop substance use are related to negative symptoms. 
There was no relationship of the change language with alogia. 
MICO behaviors and change language. The pattern of relationships between 
MICO behaviors and change language changed significantly when considering prompted 
client language. The relationship of MICO behaviors to the frequency of Desire (r = .75, 
p < .001) and Commitment (r = .34, p < .05) became significant; Reasons language 
stayed significant (r = .75, p < .001), and Ability language approached significance (r = 
.29, p = .06). Therefore, when considering both therapist-prompted and unprompted 
change language statements, therapists’ increased use of MICO behaviors are associated 
with increased frequency of client statements related to desire, reasons, and commitment 
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(and possibly Ability) to reduce/stop substance use; however, when only considering 
unprompted language, only increased Reasons language is related. 
Discussion 
The current study supports the idea that the frequency of change language is rated 
reliably whether unprompted or prompted language is considered.  Reliable strength 
ratings were difficult to ascertain when considering prompted or unprompted language. 
There were few notable differences with respect to the remaining analyses. The 
differences that did emerge may have been a result of increased available data (because 
both prompted and unprompted statements were analyzed) and therefore increased power 
to detect effects. Further research is warranted to garner more solid conclusions regarding 
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SUPERVISED CLINICAL EXPERIENCE 
 
2010-2011 Psychology Intern, VA Long Beach Healthcare System, Long 
Beach, CA. Rotations include: Substance Abuse Treatment Center, 
Assessment/Psychotherapy, PTSD/Substance Abuse, Spinal Cord 
Injury, and Outpatient Mental Health Clinic.  
Supervisors: Henry Benedict, Ph.D., Kenneth Cole, Ph.D., Deirdre 
Lopez, Ph.D., Linda Mona, Ph.D., and Anna McCarthy, Ph.D. 
Duties: Conduct group and individual therapy for individuals who 
have depression, anxiety, and substance use disorders. Administer 
psychological assessments. Co-developed and facilitated stress 
management group. Weekly group and individual supervision with 
seminars and case conferences. Participation in interdisciplinary 
substance abuse treatment team meetings. Developed 
programming for residential substance use treatment program for 
Spinal Cord Injury unit. Developed VA training module on 
substance use for caregivers of spinal cord injured patients. 
Therapeutic Approaches: Cognitive-Behavioral, Motivational 
Interviewing, Acceptance and Commitment, Mindfulness, 
Prolonged Exposure, Cognitive Processing Therapy, Interpersonal, 
Relapse Prevention for Substance Abuse, Dual Diagnosis. 
 
2009-2010 Extern, Baltimore Veterans Affairs Medical Center and University 
of Maryland School of Medicine 
Supervisor: Melanie Bennett, Ph.D. 
Conducted Social/Coping skills groups for individuals with severe 
mental illness in the Psychosocial Rehabilitation and Recovery 
Center. Facilitated social skills groups for individuals with severe 
mental illness and substance use disorders. Trained in Motivational 
Interviewing approaches to conducting therapy. Trained in 
substance use assessment (e.g., Addiction Severity Index and 
Substance Use Event Survey for Severe Mental Illness). Attended 
group supervision meetings for all activities listed and for 
behavioral smoking cessation groups. 
2008-2009 Clinical Practicum Therapist, Child Assessment and Therapy, 
University of Maryland, College Park.  
Supervisors: M. Colleen Byrne, Ph.D., Andres DeLos Reyes, 
Ph.D. and Lea Dougherty, Ph.D. 
Conducted psychoeducational assessments and synthesized reports 
for children with learning disabilities and Attention Deficit 
Hyperactivity Disorder (ADHD). Assessment included the Kiddie 
Schedule for Affective Disorders for School-Aged Children, DSM-
IV Interview, Wechsler Individual Achievement Test, 2
nd
 Edition, 
and the Wechsler Intelligence Scale for Children, 4
th
 Edition. 
Provided Parent Behavioral Training for ADHD to parents of one 
child with ADHD and one child with ADHD and Oppositional 
Defiant Disorder (ODD). Provided coping skills training to a child 
with ADHD and ODD. Provided consultation and psychoeducation 
to teachers, counselors, and parents for child’s Individualized 
Education Plan meeting. Attended weekly group and individual 
supervision. 
2006-2009 Clinical Practicum Therapist, Adult Therapy, University of 
Maryland, College Park. 
 Supervisors: M. Colleen Byrne, Ph.D., Lea Dougherty, Ph.D., 
Andrea Chronis-Tuscano, Ph.D., and Andres De Los Reyes, Ph.D. 
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Supervisors: M. Colleen Byrne, Ph.D., Jeff Wilken, Ph.D., and 
Andres DeLos Reyes, Ph.D. 
Conducted neuropsychological and psychoeducational assessments 
for adults, interpreting results, report writing, and providing 
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nd
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nd
 Edition, 
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nd
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Ph.D. 
Lead therapist in a treatment outcome study examining the 
effectiveness of a group format brief behavioral activation 
treatment for depression in depressed substance users currently 
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and validly measured in this population. Examined the relationship 
between symptomatology and self-motivational statements. 
Explored the relationship between these statements and substance 
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coding, wrote SPSS syntax to manage and aggregate large data 
sets. Performed all statistical analyses.  
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Ph.D. 
Project coordinator of a research study examining the role of 
distress tolerance in substance use treatment outcomes. Project 
assistant for NIDA-funded R01 grant examining drug choice and 
risky sexual behavior; duties included assessment coordination and 
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biobehavioral mechanisms underlying Antisocial Personality 
Disorder and the role of psychopathic traits in treatment-seeking 
substance users. Co-developed behavioral intervention (and 
accompanying manual) that aimed to reduce health risk behaviors 
in freshman entering the University of Maryland. Developed 
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the utility of a Behavioral Activation intervention in reducing 
depressive symptoms among treatment-seeking substance users. 
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the utility of the Balloon Analogue Risk Taking task as a predictor 
of adolescent risk behaviors. 
2003-2005 Research Assistant, Veterans Affairs Medical Center, Long Beach 
and California State University, Long Beach 
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Investigated the relation among cognitive functioning, Attention 
Deficit Hyperactivity Disorder (ADHD), and drinking habits. 
Conducted independent research examining general and drinking-
related locus of control within the 12-Step paradigm of Alcoholics 
Anonymous. Examined the factor structure of Attention Deficit 




2004 Research Experience for Undergraduates, Translational 
Research in Cognitive and Affective Mechanisms Laboratory 
University of Minnesota, Department of Psychology 
Supervisor: Angus MacDonald, Ph.D. 
Investigated personality correlates of decision-making in economic 
games.  Specific tasks included performing analyses on data 
obtained from economic games and on Multidimensional 
Personality Questionnaire data using SPSS and Sigma Plot. 
2003 Independent Research, Career Opportunities in Research and 
Education Laboratory, California State University, Long Beach 
Supervisors: John R. Jung, Ph.D. and Chi-Ah Chun, Ph.D. 
Performed a secondary analysis of the Gambling Commission’s 
1997 Gambling Impact and Behavior Study investigating 
depressive symptoms and problem gambling behaviors in 
pathological, problem, and low-risk gamblers. 
 
TEACHING EXPERIENCE AND INVITED LECTURES 
Spring 2011 Instructor, Community Psychology, California State University, 
Long Beach. 
November 2010 Invited Guest Lecturer, Schizophrenia, Abnormal Psychology, 
California State University, Long Beach. 
April 2010  Psychology Department Colloquium Speaker, Conducting 
Meta-analyses, University of Maryland, College Park. 
October 2009 Invited Guest Lecturer, General Psychopathology, Introduction 
to Behavioral Science, University of Maryland, University 
College. 
Fall 2009- Teaching Assistant, Introduction to Psychology, University of 
Maryland,  
Spring 2010 College Park. Prepared and gave lectures on general topics in 
psychology. 
October 2006 Invited Guest Lecturer, Etiology and Phenomenology of Conduct 
Disorder, Antisocial Personality Disorder, and Psychopathy, 
Abnormal Psychology, University of Maryland, College Park. 
 
PROFESSIONAL SERVICE AND ACTIVITIES 
 
October 2010- Ad-Hoc Reviewer, Personality Disorders: Theory, Research, and 
present  Treatment. 
August 2010- Editorial Board Member, The New School Psychology Bulletin. 
present 
 
January 2006 Student Reviewer, Personality and Individual Differences.  
January 2009- Student Consultant, Design and Statistical Analysis Laboratory,  
May 2010 University of Maryland, College Park. Under the direction of Dr. 
Kevin O’Grady, provided statistical design and analysis 
consultation to faculty and students.  
2008-2009 Mentor, Achieving College Excellence Learning Community 
Mentorship Program, University of Maryland, College Park. 
2008 UMD Clinical Psychology Program Student Representative, 
APA Roundtable Discussion with APA President, Alan Kazdin. 
APA Headquarters, Washington D.C.  
2007 Faculty Search Committee Student Representative, Clinical 
Psychology Program, University of Maryland, College Park. 
2006 Community Outreach Leader, Boys and Girls Club of 
Germantown and University of Maryland Terpquest Day Camp. 
Co-developed and administered health risk behavior prevention 
workshops for children and adolescents. 
 
AWARDS AND HONORS 
 
2005- Sally Casanova Pre-Doctoral Scholar, California State 
University 
present Chancellor’s Office. 
2008 Multicultural Excellence National Summer Institute Fellow, 
University of Denver, Denver, CO. 
2007 National Institute on Drug Abuse Early Career Investigators 
Travel Award, American Psychological Association Convention, 
San Francisco, CA. 
2006  1st Place in PROMISE Research Symposium Poster 
Competition, University of Maryland (Baltimore and College 
Park). 
2005  Most Outstanding Graduate in the Department of Psychology, 
California State University, Long Beach. 
2005  Outstanding Graduate in the College of Liberal Arts, California 
State University, Long Beach. Selected to give commencement 
speech at graduation ceremony. 
2003-2005 National Institute of Mental Health Career Opportunities in 
Research Education and Training (COR) Scholar (T34 grant), 
California State University, Long Beach. Selected through a 
competitive process to participate in training program for 
undergraduates seeking to pursue careers in the area of mental 
health. 
 
2004 Distinguished Student, Fall Convocation, California State 
University, Long Beach.  
 Selected based on excellent academic record and research 
activities. 
2004 2nd Place in California State University Statewide Research 
Competition, California State University System. 
2004 2
nd
 Place in California State University, Long Beach Research 
Competition.     
 
 
 
 
 
 
 
